,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes,dataset_train
0,gsea,PI3K-Akt signaling pathway,0.5728644528289687,2.8811428976922264,0.0,0.0,0.0,101/289,25.01%,ITGA8;OSM;FGF10;FGF16;FGF5;GNGT1;PDGFRA;CD19;LPAR3;THBS2;LAMC3;EIF4E1B;TNC;EPO;FLT3;COL2A1;EREG;FGF6;LPAR4;COL4A6;ANGPT1;FGF23;CHRM1;ITGB7;IL2RG;COL4A3;COL6A2;IL7R;LAMB2;IL2RA;LAMA1;IGF2;COL1A1;LPAR5;ITGA11;PCK1;PKN3;CSF3;TNN;IL4;PIK3R6;FGF17;GNB3;NTF3;PDGFRB;GNG8;THBS4;FGF20;IGF1;PDGFD;ITGB4;FGF21;GNG13;COL9A1;EFNA3;FGF7;SYK;TLR4;LAMA4;OSMR;COL6A5;NGFR;COL6A1;FGF2;KDR;TEK;RELN;ERBB2;FGFR3;CREB3L4;CHAD;EGF;PIK3AP1;ITGA7;IL2RB;CDK6;FN1;GNG11;EPOR;PIK3CG;FLT4;NGF;VWF;FGF18;PDGFC;COL4A5;GNGT2;CREB3L3;IL7;ERBB4;FGFR4;MYB;LAMB3;ITGA5;KIT;CHRM2;SOS2;IL6;VTN;FGF22;GNG10,combination
1,gsea,JAK-STAT signaling pathway,0.6279059092163014,2.782711749284514,0.0,0.0,0.0,40/113,24.44%,IL24;OSM;IFNE;PDGFRA;IL22RA1;IL19;IL13RA2;IL21R;IFNG;IL12RB2;EPO;IL12A;IL2RG;IL15;LEPR;GFAP;IL7R;IL2RA;IL23R;IL21;IL5RA;LEP;CSF3;IL4;IL5;IL10RA;MPL;PDGFRB;IL22RA2;OSMR;IL10;EGF;IL2RB;EPOR;IL7;IL20RA;SOS2;IL6;SOCS1;STAT4,combination
2,gsea,Wnt signaling pathway,0.5612643592214138,2.7609955567286097,0.0,0.0,0.0,38/128,24.79%,SFRP2;RSPO2;LEF1;WNT2;WNT8A;NKD1;WNT8B;WNT3A;RSPO3;WNT11;RSPO1;FZD10;DKK2;SFRP1;MMP7;WNT2B;DAAM2;FZD4;TCF7;SFRP4;NOTUM;WNT6;WNT7A;SOX17;PLCB2;DKK1;RAC2;LGR5;WNT16;CAMK2A;WNT7B;PRICKLE4;FZD9;WNT9A;WNT10A;LGR6;WIF1;FZD2,combination
3,gsea,Regulation of actin cytoskeleton,0.5255171535153487,2.732382150311196,0.0,0.0,0.0,51/183,24.82%,ITGA8;FGF10;FGF16;FGF5;PDGFRA;ITGAL;MYL2;FGF6;LPAR4;FGF23;CHRM1;ITGB7;MYL10;NCKAP1L;LPAR5;CHRM5;ITGA11;WAS;FGF17;ITGAM;MYLK3;MYLK4;PDGFRB;FGD3;FGF20;PDGFD;ITGB4;FGF21;ITGAX;MYLK2;FGF7;MYLK;PFN4;RAC2;FGF2;FGFR3;BDKRB1;EGF;ITGA7;FN1;ITGAE;FGF18;PDGFC;CXCR4;VAV1;FGFR4;ITGA5;CHRM2;SOS2;MYL7;FGF22,combination
4,gsea,Sphingolipid metabolism,0.744629646613359,2.722926081252393,0.0,0.0,0.0,4/34,3.33%,ACER1;CERS3;SPTLC3;ENPP7,combination
5,gsea,Serotonergic synapse,0.5892346317340967,2.716848950635186,0.0,0.0,0.0,33/87,25.01%,HTR3B;PLA2G4D;GNGT1;ALOX12;PLA2G4E;ALOX15;HTR4;PLA2G4F;HTR2A;GABRB2;CACNA1S;TPH1;HTR6;HTR2C;GNB3;HTR1F;PLA2G4C;GNG8;HTR2B;GNG13;HTR3A;PLCB2;HTR7;HTR5A;PLA2G4A;GNG11;GNGT2;KCNJ5;SLC6A4;PTGS1;PTGS2;SLC18A2;GNG10,combination
6,gsea,Human papillomavirus infection,0.4968071285955322,2.6959249648528467,0.0,0.0,0.0,85/270,31.31%,ITGA8;WNT2;TBPL2;WNT8A;ATP6V1E2;THBS2;LAMC3;TNC;ATP6V0D2;COL2A1;WNT8B;COL4A6;WNT3A;ITGB7;HES2;WNT11;COL4A3;COL6A2;FZD10;LAMB2;CCNA1;LAMA1;ATP6V1B1;COL1A1;WNT2B;ITGA11;TNN;FZD4;TCF7;WNT6;WNT7A;ATP6V1C2;PDGFRB;THBS4;ITGB4;COL9A1;LAMA4;COL6A5;COL6A1;LFNG;RELN;WNT16;CREB3L4;CHAD;EGF;ITGA7;WNT7B;CDK6;FN1;FZD9;VWF;WNT9A;WNT10A;COL4A5;RBPJL;CCNA2;CREB3L3;HEY1;HEY2;LAMB3;ITGA5;SOS2;PTGS2;VTN;FZD2;ATP6V0A4;COL1A2;NOTCH3;COL4A4;AXIN2;WNT10B;ITGB6;THBS1;THBS3;RBL1;ITGA1;LAMB1;APC2;APC;COL4A2;DLG2;MTOR;LAMA5;CDK2;HEYL,combination
7,gsea,Transcriptional misregulation in cancer,0.536473926876527,2.6785830611472514,0.0,0.0,0.0,41/142,27.38%,PAX8;HOXA9;TLX1;PAX3;RXRG;MPO;FLT3;MMP3;PAX5;ITGB7;SPI1;WT1;MMP9;FLI1;CCNA1;TRAF1;PAX7;ITGAM;IGF1;LYL1;ERG;CEBPE;NGFR;WNT16;ETV4;CD40;IL2RB;CD86;PLAU;BCL11B;PTCRA;SLC45A3;HMGA2;CD14;IL6;ETV5;RUNX1;MAF;FLT1;TGFBR2;RUNX2,combination
8,gsea,Ras signaling pathway,0.5290750313945931,2.6617187172949297,0.0,0.0,0.0,72/192,31.65%,PLA2G4D;FGF10;FGF16;FGF5;GNGT1;PDGFRA;PLA2G4E;FLT3;FGF6;ANGPT1;FGF23;PLA2G4F;IGF2;PLA2G5;RASGRP3;FGF17;GNB3;GRIN2B;NTF3;PDGFRB;PLA2G4C;GNG8;PLA2G12B;FGF20;IGF1;PDGFD;FGF21;GNG13;EFNA3;FGF7;PLA2G2C;RASGRP4;HTR7;RAC2;NGFR;FGF2;KDR;PLA2G4A;TEK;FGFR3;EGF;RASAL1;GNG11;RAPGEF5;FLT4;NGF;FGF18;PDGFC;SHC3;GNGT2;FGFR4;PLCE1;KIT;SOS2;FGF22;GNG10;PLD2;GRIN2A;PLA1A;FLT1;PLA2G2D;CALML4;LAT;RASGRP1;FGFR2;PLCG2;BRAP;TIAM1;ETS1;CSF1R;GNG3;RASGRP2,combination
9,gsea,Pathways in cancer,0.5211578343047539,2.653748525562488,0.0,0.0,0.0,162/440,31.65%,LEF1;MMP2;PAX8;FGF10;FGF16;FGF5;GNGT1;PDGFRA;WNT2;WNT8A;RXRG;LPAR3;IFNG;IL12RB2;LAMC3;MGST2;EPO;BIRC7;NOS2;FLT3;HHIP;FGF6;WNT8B;IL12A;LPAR4;COL4A6;WNT3A;FGF23;SPI1;IL2RG;IL15;GLI1;WNT11;PTGER2;COL4A3;SHH;FZD10;IL7R;MMP9;LAMB2;IL2RA;TRAF1;LAMA1;IGF2;KIF7;IL23R;NKX3-1;WNT2B;LPAR5;IL5RA;RASGRP3;ESR2;IL4;FZD4;FGF17;TCF7;BMP4;GNB3;IL5;WNT6;WNT7A;PDGFRB;GNG8;CTNNA3;GLI2;ESR1;FGF20;IGF1;FGF21;AR;DCC;GNG13;PMAIP1;PLCB2;DAPK2;FGF7;RASGRP4;LAMA4;RAC2;FGF2;RARB;ERBB2;FGFR3;WNT16;BDKRB1;EGF;CAMK2A;WNT7B;PTGER1;IL2RB;CDK6;FN1;GNG11;EPOR;GLI3;FLT4;F2RL3;FZD9;NQO1;WNT9A;FGF18;WNT10A;CXCR4;COL4A5;GNGT2;EGLN3;HEY1;IL7;HEY2;ADCY8;FGFR4;LAMB3;KIT;BIRC5;SOS2;PTGS2;IL6;STAT4;SKP2;EDNRB;FZD2;FGF22;ALK;DLL3;GNG10;PTGER3;RUNX1;PTCH2;NOTCH3;CSF3R;COL4A4;TGFBR2;AXIN2;WNT10B;FRAT2;ADCY7;CALML4;SMAD3;RASGRP1;EDN1;LAMB1;FGFR2;PLCG2;APC2;APC;COL4A2;EDNRA;ADCY5;MTOR;LAMA5;TGFB1;BID;IL23A;BRCA2;CDK2;ETS1;CSF1R;ZBTB16;IL12RB1;HEYL;GNG3;RASGRP2,combination
10,gsea,Focal adhesion,0.515541537690895,2.642734082923492,0.0,0.0,0.0,65/177,30.80%,ITGA8;PDGFRA;MYL2;THBS2;LAMC3;TNC;COL2A1;COL4A6;ITGB7;MYL10;COL4A3;COL6A2;PARVG;LAMB2;LAMA1;COL1A1;ITGA11;TNN;MYLK3;MYLK4;PDGFRB;THBS4;IGF1;PDGFD;ITGB4;MYLK2;COL9A1;CAV3;MYLK;LAMA4;RAC2;COL6A5;COL6A1;KDR;RELN;FLNC;ERBB2;CHAD;EGF;ITGA7;FN1;FLT4;VWF;PDGFC;COL4A5;SHC3;VAV1;LAMB3;ITGA5;SOS2;VTN;MYL7;COL1A2;FLT1;COL4A4;ITGB6;THBS1;THBS3;ITGA1;LAMB1;CAV1;TLN2;PARVB;COL4A2;LAMA5,combination
11,gsea,Chemokine signaling pathway,0.5427404948004407,2.64053445117519,0.0,0.0,0.0,41/139,23.90%,CXCR1;CCR4;ITK;GNGT1;FGR;CCR3;CCR6;CCL17;XCR1;CXCR3;CCL19;DOCK2;PPBP;CXCR6;WAS;HCK;PIK3R6;GNB3;CCL24;GNG8;CXCL9;CX3CR1;CCR9;GNG13;CXCL14;CCR7;PLCB2;CCL20;NCF1;RAC2;CXCR2;GNG11;PIK3CG;CXCR4;SHC3;VAV1;GNGT2;CCL22;ADCY8;CXCL13;SOS2,combination
12,gsea,Melanoma,0.5995054448356022,2.62413712057023,0.0,0.0,0.0,18/61,21.98%,FGF10;FGF16;FGF5;PDGFRA;FGF6;FGF23;FGF17;PDGFRB;FGF20;IGF1;PDGFD;FGF21;FGF7;FGF2;EGF;CDK6;FGF18;PDGFC,combination
13,gsea,MAPK signaling pathway,0.4913036632402066,2.584459526845621,0.0,0.0,0.0,59/255,24.82%,PTPN5;PLA2G4D;FGF10;FGF16;FGF5;PDGFRA;PLA2G4E;FLT3;EREG;FGF6;ANGPT1;FGF23;PLA2G4F;CACNG5;CACNA1S;IGF2;CACNG1;PTPN7;RASGRP3;FGF17;NTF3;PDGFRB;PLA2G4C;FGF20;CACNG8;IGF1;PDGFD;FGF21;CACNG6;EFNA3;FGF7;RASGRP4;RAC2;NGFR;FGF2;KDR;PLA2G4A;TEK;FLNC;ERBB2;FGFR3;EGF;CDC25B;MAP4K1;IL1A;CACNG7;FLT4;NGF;FGF18;PDGFC;MAP3K6;ERBB4;FGFR4;KIT;CD14;SOS2;DUSP9;CACNG3;FGF22,combination
14,gsea,Leukocyte transendothelial migration,0.5530255516703177,2.5713278640202795,0.0,0.0,0.0,33/93,27.54%,MMP2;CLDN19;ITK;CLDN16;ITGAL;CLDN18;MYL2;CLDN14;MYL10;CLDN10;NCF4;MMP9;ITGAM;CLDN4;RHOH;CTNNA3;CLDN5;CLDN15;NCF2;THY1;CLDN8;NCF1;RAC2;TXK;CXCR4;VAV1;CLDN11;VCAM1;CLDN2;MYL7;ESAM;CLDN9;CDH5,combination
15,gsea,Synaptic vesicle cycle,0.5550323800372194,2.560880332751365,0.0,0.0,0.0,25/66,24.17%,SLC17A7;ATP6V1E2;ATP6V0D2;SLC6A1;SLC6A12;SLC6A7;SLC1A7;SLC17A6;ATP6V1B1;CPLX4;SLC6A5;UNC13C;ATP6V1C2;SLC6A2;SLC6A13;CPLX1;SLC1A2;SLC1A3;SLC6A11;SLC1A6;STX1A;STX2;SLC17A8;SLC6A4;SLC18A2,combination
16,gsea,Proteoglycans in cancer,0.4760227359991034,2.557347627832474,0.0,0.0,0.0,66/176,35.36%,LUM;MMP2;HOXD10;WNT2;WNT8A;WNT8B;WNT3A;WNT11;HPSE2;SHH;FZD10;MMP9;IGF2;COL1A1;WNT2B;FZD4;WNT6;WNT7A;ESR1;IGF1;CAV3;GPC3;TLR4;TWIST1;HCLS1;FGF2;KDR;DCN;FLNC;ERBB2;WNT16;CAMK2A;WNT7B;FN1;PLAU;FZD9;SDC1;WNT9A;WNT10A;ERBB4;ITGA5;PLCE1;SOS2;TIMP3;VTN;FZD2;HSPG2;IHH;COL1A2;WNT10B;THBS1;CAV1;PLCG2;TIAM1;MTOR;TGFB1;PLAUR;FZD1;RPS6KB2;VAV2;SMO;WNT5A;FZD6;CAMK2G;CAV2;HGF,combination
17,gsea,Adrenergic signaling in cardiomyocytes,0.49682830097430497,2.552545278839007,0.0,0.0,0.0,45/126,32.91%,ATP2B3;KCNE1;MYH6;ATP1A4;SCN5A;MYL2;AGTR2;PLN;ADRA1D;TNNT2;SCN7A;CACNG5;SCN4B;CACNA1S;CACNG1;TNNI3;MYL3;PIK3R6;ATP1A2;MYH7;CACNG8;CACNG6;PLCB2;CREB3L4;CAMK2A;CACNG7;PIK3CG;CREB3L3;ADCY8;CACNG3;RYR2;ACTC1;ADCY7;CALML4;ATP1A3;PIK3R5;ADCY5;CACNB4;ADRA1B;ADRB1;ADCY1;ADCY2;RAPGEF3;FXYD2;SLC8A1,combination
18,gsea,Phospholipase D signaling pathway,0.5531066610923957,2.538137941766216,0.0,0.0,0.0,41/128,28.93%,AVPR2;CXCR1;PLA2G4D;GRM3;AVP;GRM7;PDGFRA;GRM6;LPAR3;PLA2G4E;PTGFR;MS4A2;LPAR4;GRM2;PLA2G4F;LPAR5;PIK3R6;PDGFRB;PLA2G4C;PDGFD;PLCB2;SYK;CYTH4;PLA2G4A;EGF;CXCR2;PIK3CG;GRM1;PDGFC;SHC3;DGKI;ADCY8;KIT;SOS2;PLD2;SPHK1;GRM8;ADCY7;GRM4;GRM5;PIK3R5,combination
19,gsea,cAMP signaling pathway,0.5075001161836956,2.517730951540802,0.0,0.0,0.0,78/184,33.26%,FSHR;ATP2B3;ATP1A4;GRIA4;ADCYAP1;HHIP;CGA;HTR4;GRIA1;CHRM1;PLN;GLI1;CNGA3;PTGER2;CACNA1S;TNNI3;ARAP3;CFTR;HTR6;AMH;ATP1A2;GRIN2B;HTR1F;GRIN3A;SSTR5;CNGA4;TSHR;PPP1R1B;ADCY10;DRD2;RAC2;CNGA1;GIP;SUCNR1;CREB3L4;CAMK2A;GRIN3B;NPPA;GLI3;ADCYAP1R1;NPY1R;GRIN2D;VIPR2;VAV1;CREB3L3;ADCY8;PLCE1;CHRM2;CNGB1;VIP;SSTR1;RYR2;PTGER3;PLD2;GRIN2A;PDE4C;FXYD1;GHRL;ADCY7;SSTR2;CALML4;ATP1A3;PDE3A;EDN1;PPARA;EDNRA;ADCY5;TIAM1;NPR1;GRIA3;ADRB1;ADCY1;OXTR;ACOX3;ADCY2;RAPGEF3;FXYD2;VAV2,combination
20,gsea,Rap1 signaling pathway,0.5018921687425271,2.513467456078655,0.0,0.0,0.0,70/178,32.92%,FGF10;FGF16;FGF5;PDGFRA;FPR1;LPAR3;ITGAL;FGF6;LPAR4;ANGPT1;FGF23;LPAR5;ARAP3;RASGRP3;FGF17;APBB1IP;ITGAM;GRIN2B;PDGFRB;FGF20;IGF1;PDGFD;FGF21;PLCB2;EFNA3;FGF7;DRD2;PFN4;RAC2;NGFR;FGF2;KDR;TEK;FGFR3;EGF;CNR1;LCP2;RAPGEF5;FLT4;F2RL3;NGF;FGF18;PDGFC;RGS14;ADCY8;FGFR4;PLCE1;KIT;FGF22;GRIN2A;PRKD2;FLT1;THBS1;ADCY7;CALML4;LAT;FGFR2;DOCK4;TLN2;MAGI3;ADCY5;TIAM1;CSF1R;RASGRP2;ADCY1;LPAR1;PARD6B;ADCY2;RAPGEF3;FGF1,combination
21,gsea,Signaling pathways regulating pluripotency of stem cells,0.5493581064507894,2.51005463294769,0.0,0.0,0.0,40/116,30.10%,ONECUT1;DLX5;WNT2;WNT8A;ESRRB;INHBC;WNT8B;WNT3A;WNT11;NODAL;SOX2;FZD10;HESX1;WNT2B;FZD4;BMP4;WNT6;WNT7A;TBX3;LHX5;IGF1;INHBE;FGF2;FGFR3;WNT16;WNT7B;FZD9;WNT9A;WNT10A;FGFR4;DUSP9;FZD2;INHBB;AXIN2;WNT10B;LIF;SMAD3;FGFR2;APC2;APC,combination
22,gsea,Glycerophospholipid metabolism,0.5678870166198424,2.509371328004535,0.0,0.0,0.0,21/74,25.78%,PLA2G4D;PLA2G4E;PLA2G4F;PLD4;PLA2G5;CHAT;PLA2G4C;PHOSPHO1;PLA2G12B;PLA2G2C;PLA2G4A;GPAT2;ETNPPL;LPCAT2;GPAM;LPIN3;DGKI;LCAT;PLD2;PLB1;PEMT,combination
23,gsea,cGMP-PKG signaling pathway,0.4848341049833629,2.508749811731708,0.0,0.0,0.0,58/141,35.00%,ATP2B3;ATP1A4;KCNJ8;ADRB3;ADRA2B;SLC8A3;OPRD1;PLN;ADRA1D;ADRA2C;KCNMB3;CACNA1S;PRKG2;PDE2A;PIK3R6;ATP1A2;MYLK3;MYLK4;MYH7;MYLK2;NPPC;TRPC6;PLCB2;ATP2A1;MYLK;CNGA1;CREB3L4;NPPA;PIK3CG;CREB3L3;ADCY8;SLC25A31;CNGB1;EDNRB;NPPB;PRKG1;ADCY7;CALML4;ATP1A3;PDE3A;PIK3R5;GUCY1A2;NPR2;EDNRA;ADCY5;NPR1;ADRA1B;GTF2IRD1;ADRB1;ADCY1;ADCY2;FXYD2;SLC8A1;KCNMB4;ADORA3;ADRA1A;CACNA1F;INSR,combination
24,gsea,Rheumatoid arthritis,0.5926504256702423,2.4946613143488308,0.0,0.0,0.0,21/57,20.21%,TNFSF11;ITGAL;ATP6V1E2;IFNG;ATP6V0D2;MMP3;ANGPT1;IL15;CD80;PTH;CD28;ATP6V1B1;ATP6V1C2;CTLA4;ACP5;IL17A;TLR4;CCL20;TEK;IL1A;CD86,combination
25,gsea,IL-17 signaling pathway,0.5453688636114995,2.4936749566569274,0.0,0.0,0.0,15/73,17.04%,IL17B;S100A8;CCL17;IFNG;MMP3;MUC5B;MMP9;CSF3;IL17RB;IL4;IL5;IL17C;LCN2;IL17A;CCL20,combination
26,gsea,Glutamatergic synapse,0.5798277753129002,2.4831870582114624,0.0,0.0,0.0,49/99,31.89%,PLA2G4D;GRM3;GNGT1;GRM7;GRIA4;SLC17A7;GRM6;PLA2G4E;GRIK1;GRIA1;GRM2;PLA2G4F;SLC1A7;SLC17A6;GNB3;GRIN2B;GRIN3A;PLA2G4C;GNG8;GNG13;PLCB2;SLC1A2;PLA2G4A;SLC38A1;SLC1A3;GRIN3B;SLC1A6;GNG11;GRM1;GRIN2D;SLC17A8;HOMER2;GNGT2;ADCY8;GNG10;PLD2;GRIN2A;GRM8;GRIK4;ADCY7;GRM4;GRM5;GRIK3;GRIK2;ADCY5;GRIA3;GNG3;HOMER3;ADCY1,combination
27,gsea,Th17 cell differentiation,0.5400281212597768,2.475760742198829,0.0,0.0,0.0,32/82,33.07%,TBX21;CD3E;RXRG;IL21R;IFNG;IL2RG;CD3G;IRF4;IL2RA;IL23R;IL21;IL4;PRKCQ;GATA3;FOXP3;CD3D;IL17A;CD4;IL2RB;IL6;CD247;RUNX1;TGFBR2;LAT;SMAD3;MTOR;TGFB1;IL23A;IL12RB1;LCK;IL17D;TGFBR1,combination
28,gsea,Relaxin signaling pathway,0.49078514761794023,2.475463373601997,0.0,0.0,0.0,42/111,33.07%,RXFP1;MMP2;GNGT1;NOS2;COL4A6;COL4A3;INSL3;RXFP4;MMP9;COL1A1;GNB3;GNG8;NOS1;GNG13;PLCB2;CREB3L4;GNG11;ACTA2;COL4A5;GNA15;SHC3;GNGT2;CREB3L3;ADCY8;MMP13;SOS2;EDNRB;GNG10;COL1A2;RXFP2;COL4A4;TGFBR2;ADCY7;SMAD3;EDN1;COL4A2;ADCY5;TGFB1;GNG3;ADCY1;ADCY2;TGFBR1,combination
29,gsea,T cell receptor signaling pathway,0.5442602993112767,2.4732387119735115,0.0,0.0,0.0,21/85,24.64%,CD40LG;CD3E;ITK;CD8A;IFNG;CD3G;CARD11;CD28;IL4;IL5;PRKCQ;CTLA4;CD3D;CD4;ICOS;IL10;LCP2;GRAP2;VAV1;SOS2;CD247,combination
30,gsea,Th1 and Th2 cell differentiation,0.5862864641884612,2.4714290284404035,0.0,0.0,0.0,22/68,26.61%,TBX21;CD3E;IFNG;IL12RB2;IL12A;IL2RG;CD3G;IL2RA;IL4;IL5;PRKCQ;GATA3;RUNX3;CD3D;CD4;IL2RB;RBPJL;STAT4;CD247;DLL3;NOTCH3;MAF,combination
31,gsea,Viral myocarditis,0.6650331189128929,2.4664922027615135,0.0,0.0,0.0,12/32,20.21%,CD40LG;PRF1;MYH6;ITGAL;SGCG;CD80;CD28;MYH7;RAC2;SGCA;CD40;CD86,combination
32,gsea,Melanogenesis,0.516699594446459,2.4641060080324646,0.0,0.0,0.0,40/84,34.74%,LEF1;WNT2;WNT8A;WNT8B;WNT3A;WNT11;TYRP1;TYR;FZD10;WNT2B;FZD4;TCF7;WNT6;WNT7A;PLCB2;WNT16;CREB3L4;CAMK2A;WNT7B;FZD9;WNT9A;WNT10A;CREB3L3;ADCY8;KIT;EDNRB;FZD2;MC1R;WNT10B;ADCY7;CALML4;EDN1;ADCY5;ADCY1;ADCY2;FZD1;DCT;WNT5A;FZD6;CAMK2G,combination
33,gsea,Hippo signaling pathway,0.5243202737509037,2.462918422400884,0.0,0.0,0.0,57/137,33.07%,LEF1;WNT2;AFP;GDF5;WNT8A;BMP5;NKD1;WNT8B;WNT3A;GDF6;WNT11;SOX2;FZD10;WNT2B;FZD4;AMH;TCF7;BMP4;WNT6;WNT7A;TEAD4;CRB2;CTNNA3;GLI2;DCHS1;AJUBA;WNT16;TEAD2;WNT7B;FZD9;WNT9A;WNT10A;BMP7;BIRC5;FZD2;YAP1;WWTR1;LATS2;TGFBR2;AXIN2;WNT10B;SMAD3;FAT4;TEAD3;APC2;APC;CRB1;SNAI2;DLG2;TGFB1;SERPINE1;AMOT;PARD6B;FGF1;FZD1;RASSF4;TGFBR1,combination
34,gsea,Breast cancer,0.5683693368413792,2.4597687756992235,0.0,0.0,0.0,45/124,24.96%,LEF1;FGF10;FGF16;FGF5;WNT2;WNT8A;TNFSF11;FGF6;WNT8B;WNT3A;FGF23;WNT11;FZD10;WNT2B;ESR2;FZD4;FGF17;TCF7;WNT6;WNT7A;PGR;ESR1;FGF20;IGF1;FGF21;FGF7;FGF2;ERBB2;WNT16;EGF;WNT7B;CDK6;FLT4;FZD9;WNT9A;FGF18;WNT10A;SHC3;HEY1;HEY2;KIT;SOS2;FZD2;FGF22;DLL3,combination
35,gsea,Thyroid hormone synthesis,0.5444165116324777,2.4551025820937373,0.0,0.0,0.0,27/62,32.88%,PAX8;TG;DUOX2;ATP1A4;SLC26A4;CGA;GPX8;LRP2;ASGR2;ASGR1;ATP1A2;TSHR;PLCB2;IYD;CREB3L4;CREB3L3;ADCY8;ALB;ADCY7;ATP1A3;ADCY5;SERPINA7;SLC5A5;TPO;ADCY1;ADCY2;FXYD2,combination
36,gsea,Glycolysis / Gluconeogenesis,0.6154012208847024,2.447432768720185,0.0,0.0,0.0,14/46,21.61%,PGAM2;LDHC;ALDH3A1;ACSS1;PCK1;GAPDHS;HK2;HKDC1;ALDOB;ADH4;HK1;ADH7;FBP2;HK3,combination
37,gsea,Tight junction,0.5086534556614886,2.4420822179693165,0.0,0.0,0.0,37/129,32.71%,CLDN19;CLDN16;BVES;CLDN18;MYL2;CLDN14;MYH3;MYH8;MYH1;PRKAG3;CLDN10;WAS;CFTR;CLDN4;MYH15;CLDN5;CLDN15;MYH13;CLDN8;HCLS1;ERBB2;MPP4;CGNL1;CLDN11;MYH7B;CLDN2;MYL6B;RUNX1;CLDN9;SYNPO;MICALL2;TUBA8;TIAM1;DLG2;AMOT;CGN;PARD6B,combination
38,gsea,Vascular smooth muscle contraction,0.5099225843954178,2.436694268657323,0.0,0.0,0.0,47/110,33.02%,PLA2G4D;AVP;ACTG2;PLA2G4E;ADRA1D;PLA2G4F;KCNMB3;PTGIR;CACNA1S;PLA2G5;MYLK3;PRKCQ;ADM;MYLK4;PLA2G4C;PLA2G12B;MYLK2;NPPC;PLCB2;PLA2G2C;MYLK;PRKCH;CALCRL;PLA2G4A;NPPA;CALCB;ACTA2;ADCY8;NPPB;PRKG1;MYL6B;PLA2G2D;ADCY7;PPP1R14A;CALML4;EDN1;GUCY1A2;NPR2;EDNRA;ADCY5;NPR1;ADRA1B;PRKCD;ADCY1;RAMP3;ADCY2;KCNMB4,combination
39,gsea,Gastric cancer,0.5653160286306613,2.4309849546396016,0.0,0.0,0.0,52/126,31.09%,LEF1;FGF10;FGF16;FGF5;CDH17;WNT2;WNT8A;RXRG;REG4;FGF6;WNT8B;WNT3A;FGF23;WNT11;SHH;FZD10;WNT2B;FZD4;FGF17;TCF7;WNT6;WNT7A;CTNNA3;FGF20;FGF21;FGF7;CDX2;FGF2;RARB;ERBB2;WNT16;EGF;WNT7B;FZD9;WNT9A;FGF18;WNT10A;SHC3;SOS2;FZD2;FGF22;TGFBR2;AXIN2;WNT10B;FRAT2;SMAD3;FGFR2;APC2;APC;MTOR;TGFB1;CDK2,combination
40,gsea,Inflammatory mediator regulation of TRP channels,0.5521702020403754,2.426962488198678,0.0,0.0,0.0,26/81,23.71%,PLA2G4D;ALOX12;PLA2G4E;ASIC4;P2RY2;HRH1;PTGER2;PLA2G4F;HTR2A;TRPV4;TRPV3;TRPM8;HTR2C;PRKCQ;PLA2G4C;ASIC3;IGF1;HTR2B;PLCB2;PRKCH;PLA2G4A;BDKRB1;CAMK2A;NGF;ADCY8;TRPA1,combination
41,gsea,Long-term depression,0.5607979145041324,2.416439646148166,0.0,0.0,0.0,15/51,25.76%,PLA2G4D;PLA2G4E;RYR1;GRIA1;PLA2G4F;CRH;PRKG2;PLA2G4C;NOS1;IGF1;PLCB2;PLA2G4A;GRM1;GRID2;PRKG1,combination
42,gsea,Pancreatic secretion,0.5320215887717525,2.403959560350543,0.0,0.0,0.0,30/75,32.88%,ATP2B3;ATP1A4;CLCA2;CPA3;BST1;PLA2G5;CCKAR;CFTR;ATP1A2;SCTR;PLA2G12B;PLCB2;PLA2G2C;ATP2A1;CLCA1;SLC26A3;CD38;TPCN2;CPB2;CCK;ADCY8;RYR2;PLA2G2D;ADCY7;ATP1A3;ADCY5;ADCY1;CPA1;ADCY2;FXYD2,combination
43,gsea,Calcium signaling pathway,0.588243532763507,2.3984234310187014,0.0,0.0,0.0,73/166,26.58%,NTSR1;ATP2B3;LHCGR;PDGFRA;TACR2;ADRB3;RYR1;NOS2;PTGFR;SLC8A3;HTR4;CHRM1;TNNC2;P2RX2;PLN;ADRA1D;HRH1;HTR2A;TACR1;CACNA1S;CCKAR;CHRM5;CYSLTR1;HTR6;PLCZ1;HTR2C;P2RX7;MYLK3;MYLK4;PDGFRB;PLCD3;NOS1;CCKBR;GRPR;HTR2B;MYLK2;PLCD1;PLCB2;ATP2A1;HTR7;MYLK;HRH2;RYR3;HTR5A;ERBB2;BDKRB1;PDE1A;P2RX1;CD38;CAMK2A;TPCN2;PTGER1;P2RX3;TACR3;GRM1;GRIN2D;CXCR4;GNA15;P2RX6;ERBB4;ADCY8;SLC25A31;PLCE1;CHRM2;EDNRB;RYR2;PTGER3;GRIN2A;PTAFR;CACNA1G;SPHK1;PHKG1;PDE1B,combination
44,gsea,Tryptophan metabolism,0.657935704484793,2.3919242545528947,0.0,0.0,0.0,12/34,16.47%,CYP1A2;ACMSD;CYP1B1;IDO1;KMO;TPH1;ALDH8A1;IDO2;HAAO;AADAT;KYNU;AANAT,combination
45,gsea,Cell adhesion molecules (CAMs),0.6515146986036411,2.3892282418399717,0.0,0.0,0.0,46/98,24.58%,CD40LG;CLDN19;SELL;ITGA8;SELE;CD8A;CLDN16;ITGAL;CLDN18;CD226;CLDN14;CD6;ITGB7;CDH3;CLDN10;CD80;SELPLG;TIGIT;CD28;PDCD1LG2;VTCN1;CD22;ITGAM;CLDN4;CTLA4;SELP;NTNG2;CNTN2;CLDN5;CLDN15;CADM3;CLDN8;CD4;ICOS;CD2;CD40;MAG;ICAM2;CD86;LRRC4C;SDC1;CLDN11;VCAM1;NRXN3;CDH15;CLDN2,combination
46,gsea,Cushing syndrome,0.48025399379460953,2.3859826499929593,0.0,0.0,0.0,48/131,34.74%,LEF1;WNT2;WNT8A;WNT8B;WNT3A;WNT11;PDE11A;FZD10;CACNA1S;CRH;WNT2B;FZD4;CYP17A1;TCF7;WNT6;WNT7A;MRAP;PLCB2;WNT16;CREB3L4;CAMK2A;WNT7B;CDK6;FZD9;WNT9A;WNT10A;CREB3L3;AIPL1;ADCY8;FZD2;CACNA1G;AXIN2;WNT10B;ADCY7;KCNA4;CRHR2;APC2;APC;KCNK2;ADCY5;CDK2;ADCY1;ADCY2;FZD1;WNT5A;FZD6;CACNA1F;CAMK2G,combination
47,gsea,Toxoplasmosis,0.5119405847147985,2.381630300558437,0.0,0.0,0.0,18/84,24.39%,CD40LG;IFNG;LAMC3;BIRC7;NOS2;IL12A;LAMB2;LAMA1;PIK3R6;IL10RA;CIITA;TLR4;LAMA4;IL10;CD40;PIK3CG;LAMB3;SOCS1,combination
48,gsea,GABAergic synapse,0.5387011711749898,2.3777294147476415,0.0,0.0,0.0,36/76,32.81%,GABRA1;GNGT1;GABRA6;SLC6A1;SLC6A12;GABRA2;GABRA3;GABRB2;CACNA1S;GNB3;GAD2;GNG8;GNG13;GABRQ;GABRP;SLC6A13;GABRA5;SLC38A1;GABRR1;SLC6A11;GNG11;GNGT2;ADCY8;GABRR2;PLCL1;GABRG2;GNG10;ADCY7;GABRA4;GABRD;ADCY5;GNG3;GABRE;ADCY1;GABRB1;ADCY2,combination
49,gsea,Amoebiasis,0.5815233387637598,2.376699669330756,0.0,0.0,0.0,25/72,24.17%,C8A;C9;IFNG;LAMC3;CTSG;NOS2;IL12A;COL4A6;SERPINB13;COL4A3;LAMB2;LAMA1;COL1A1;ITGAM;ARG2;PLCB2;TLR4;LAMA4;IL10;FN1;COL4A5;GNA15;LAMB3;CD14;IL6,combination
50,gsea,Apelin signaling pathway,0.483147347552791,2.371623952961428,0.0,0.0,0.0,46/121,33.57%,GNGT1;MYL2;RYR1;NOS2;SLC8A3;PRKAG3;MYL3;PIK3R6;PLIN1;GNB3;MYLK3;MYLK4;GNG8;NOS1;MYLK2;GNG13;APLNR;PLCB2;ADCY10;MYLK;APLN;RYR3;GNG11;PIK3CG;ACTA2;GNGT2;ADCY8;RYR2;GNG10;SPHK1;UCP1;NOTCH3;ADCY7;CALML4;SMAD3;PIK3R5;ADCY5;MTOR;SERPINE1;GNG3;ADCY1;ADCY2;SLC8A1;RPS6KB2;TGFBR1;JAG1,combination
51,gsea,NF-kappa B signaling pathway,0.5446616569806374,2.3669228101334396,0.0,0.0,0.0,24/75,29.88%,CD40LG;TNFSF11;BTK;CCL19;CARD11;TRAF1;PRKCQ;TNFSF14;SYK;TLR4;CD40;TNFRSF13C;PLAU;LBP;VCAM1;CD14;PTGS2;CARD14;BLNK;CARD10;LAT;TIRAP;TNFSF13B;PLCG2,combination
52,gsea,Gastric acid secretion,0.5272849541466782,2.3641901300189394,0.0,0.0,0.0,29/63,32.81%,ATP1A4;SLC9A4;KCNJ16;KCNE2;KCNJ1;SLC26A7;CFTR;ATP1A2;MYLK3;MYLK4;KCNJ10;CCKBR;MYLK2;KCNJ15;PLCB2;MYLK;HRH2;CAMK2A;ADCY8;GAST;KCNJ2;ADCY7;SSTR2;CALML4;ATP1A3;KCNK2;ADCY5;ADCY1;ADCY2,combination
53,gsea,Platelet activation,0.4972834684660921,2.3591271292584683,0.0,3.400760299708086e-05,0.001,43/105,31.98%,PLA2G4D;PLA2G4E;BTK;GP1BA;PLA2G4F;PTGIR;COL1A1;PRKG2;PIK3R6;APBB1IP;MYLK3;MYLK4;FGB;PLA2G4C;TBXAS1;MYLK2;PLCB2;SYK;MYLK;FGG;PLA2G4A;P2RX1;LCP2;FERMT3;PIK3CG;F2RL3;VWF;ADCY8;PTGS1;PRKG1;COL1A2;ADCY7;TBXA2R;P2RY12;RASGRP1;PIK3R5;GUCY1A2;PLCG2;TLN2;ADCY5;RASGRP2;ADCY1;GP9,combination
54,gsea,Salivary secretion,0.5560782782905863,2.353728463028982,0.0,3.338928294258848e-05,0.001,30/61,32.88%,AQP5;ATP2B3;ATP1A4;LPO;ADRB3;MUC5B;BST1;ADRA1D;PRKG2;ATP1A2;CAMP;NOS1;BEST2;PLCB2;RYR3;CD38;KCNN4;ADCY8;PRKG1;ADCY7;CALML4;ATP1A3;GUCY1A2;ADCY5;DMBT1;ADRA1B;ADRB1;ADCY1;ADCY2;FXYD2,combination
55,gsea,Phagosome,0.5050534113022894,2.3472064967158723,0.0,3.2793045747185116e-05,0.001,32/92,28.00%,OLR1;PLA2R1;MARCO;ATP6V1E2;THBS2;MPO;ATP6V0D2;NCF4;ATP6V1B1;ITGAM;MRC2;ATP6V1C2;CTSS;THBS4;NOS1;MSR1;COLEC11;NCF2;TLR4;MRC1;HGS;NCF1;TUBB1;ITGA5;TUBB2B;CD14;CD36;ATP6V0A4;COLEC12;THBS1;CORO1A;THBS3,combination
56,gsea,MicroRNAs in cancer,0.47596624247209635,2.337966798870195,0.0,3.221772915512923e-05,0.001,35/125,31.49%,HOXD10;PDGFRA;SERPINB5;TNC;IGF2BP1;WNT3A;CYP1B1;CYP24A1;CDC25C;MMP9;ZFPM2;TNN;PDGFRB;RECK;ERBB2;FGFR3;CDC25B;CDK6;PLAU;VIM;ITGA5;SLC45A3;HMGA2;CDCA5;SOS2;TIMP3;PTGS2;SOCS1;NOTCH3;THBS1;PLCG2;APC2;APC;MTOR;ZEB2,combination
57,gsea,Leishmaniasis,0.5463467008573468,2.3370788036526666,0.0,3.1662251066247696e-05,0.001,11/48,19.51%,IFNG;NOS2;IL12A;NCF4;IL4;ITGAM;NCF2;TLR4;NCF1;IL10;IL1A,combination
58,gsea,Butanoate metabolism,0.6714854315875787,2.335344125839307,0.0,3.112560274309096e-05,0.001,6/22,13.44%,ACSM1;ACSM4;BDH2;HMGCS2;ACSM5;GAD2,combination
59,gsea,TGF-beta signaling pathway,0.5454664638753994,2.330795518146257,0.0,3.060684269737277e-05,0.001,24/74,28.65%,NOG;GDF5;BMP5;IFNG;INHBC;GDF6;NODAL;FMOD;AMH;BMP4;INHBE;DCN;AMHR2;SMAD6;TGIF2;FST;HAMP;BMP7;LTBP1;INHBB;TGFBR2;THBS1;RBL1;SMAD3,combination
60,gsea,Adipocytokine signaling pathway,0.5601655031330677,2.3286981834466927,0.0,3.0105091177743714e-05,0.001,13/58,25.69%,RXRG;ACSBG2;PRKAG3;LEPR;LEP;PCK1;ADIPOQ;CPT1B;PRKCQ;TNFRSF1B;ACSBG1;CAMKK2;CD36,combination
61,gsea,Choline metabolism in cancer,0.5079710476746416,2.320692835520365,0.0,2.961952519100591e-05,0.001,22/87,27.36%,PLA2G4D;PDGFRA;PLA2G4E;PLA2G4F;SLC22A3;SLC44A5;WAS;SLC22A1;PDGFRB;PLA2G4C;SLC5A7;PDGFD;RAC2;PLA2G4A;EGF;PDGFC;DGKI;SOS2;SLC22A4;PLD2;SLC22A2;WASF3,combination
62,gsea,Arginine and proline metabolism,0.6048790444209288,2.316514625590172,0.0,2.914937399749788e-05,0.001,12/38,26.09%,PRODH2;NOS2;CKMT2;DAO;NOS1;ARG2;P4HA3;CNDP1;L3HYPDH;CKM;SMOX;AGMAT,combination
63,gsea,Bile secretion,0.6437672440052383,2.3097149224924904,0.0,2.8693915028786975e-05,0.001,23/53,22.96%,CYP7A1;SLC22A8;ATP1A4;SLC51B;AQP9;ABCG5;ABCG2;SLC10A1;NR0B2;SLC27A5;CFTR;SLC22A1;ABCG8;ATP1A2;BAAT;SCTR;AQP1;SLC51A;SLC5A1;AQP8;NR1H4;ADCY8;ABCC2,combination
64,gsea,Cholinergic synapse,0.47659961732024775,2.3019001094951133,0.0,2.8252470182190254e-05,0.001,36/95,34.74%,CHRNA6;GNGT1;CHRM1;CACNA1S;CHRM5;KCNJ14;PIK3R6;GNB3;KCNQ5;CHAT;GNG8;SLC5A7;GNG13;PLCB2;CREB3L4;CHRNB4;CAMK2A;GNG11;PIK3CG;CHRNA3;GNGT2;CREB3L3;ADCY8;CHRM2;GNG10;KCNJ2;ADCY7;PIK3R5;ADCY5;GNG3;ADCY1;ADCY2;KCNJ4;KCNQ3;CACNA1F;CAMK2G,combination
65,gsea,Renin-angiotensin system,0.7479907748480097,2.2983344828003465,0.0,2.782440245215707e-05,0.001,4/17,4.80%,CMA1;CPA3;AGTR2;CTSG,combination
66,gsea,Fc epsilon RI signaling pathway,0.5427480202102015,2.293079221209651,0.0,2.7409112863318905e-05,0.001,14/55,23.90%,PLA2G4D;PLA2G4E;BTK;MS4A2;PLA2G4F;IL4;IL5;PLA2G4C;SYK;RAC2;PLA2G4A;LCP2;VAV1;SOS2,combination
67,gsea,Oxytocin signaling pathway,0.45234503610264104,2.2805570670009625,0.0,5.4012075348304904e-05,0.002,45/127,33.01%,PLA2G4D;PLA2G4E;RYR1;PRKAG3;PLA2G4F;CACNG5;CACNA1S;CACNG1;KCNJ14;PIK3R6;MYLK3;MYLK4;PLA2G4C;CACNG8;CACNG6;MYLK2;PLCB2;MYLK;RYR3;PLA2G4A;CD38;CAMK2A;CACNG7;NPPA;PIK3CG;KCNJ5;ADCY8;PTGS2;CAMKK2;CACNG3;RYR2;MYL6B;KCNJ2;ADCY7;CALML4;PIK3R5;GUCY1A2;NPR2;ADCY5;CACNB4;NPR1;ADCY1;OXTR;ADCY2;KCNJ4,combination
68,gsea,Circadian entrainment,0.4960744101766895,2.270487251147963,0.0,5.3229291647604824e-05,0.002,35/82,32.81%,GNGT1;GRIA4;RYR1;ADCYAP1;GRIA1;PRKG2;MTNR1B;GNB3;GRIN2B;GNG8;NOS1;GNG13;PLCB2;ADCY10;RYR3;CAMK2A;GNG11;ADCYAP1R1;GRIN2D;GNGT2;KCNJ5;ADCY8;RYR2;GNG10;GRIN2A;CACNA1G;PRKG1;ADCY7;CALML4;GUCY1A2;ADCY5;GRIA3;GNG3;ADCY1;ADCY2,combination
69,gsea,"Parathyroid hormone synthesis, secretion and action",0.4708809793495225,2.2484341412286777,0.0,5.246887319549618e-05,0.002,29/94,32.81%,GCM2;GCM1;RXRG;TNFSF11;SLC34A3;FGF23;CYP24A1;PTH;SLC34A2;GATA3;MMP17;PLCB2;CREB3L4;PTH1R;SLC34A1;CREB3L3;MMP14;ADCY8;MMP13;MMP25;PLD2;PDE4C;RUNX2;ADCY7;ADCY5;CYP27B1;PTHLH;ADCY1;ADCY2,combination
70,gsea,Cholesterol metabolism,0.5606947494822755,2.2451542061903287,0.0,7.759481247221267e-05,0.003,18/42,29.52%,CYP7A1;ABCG5;LRP2;SOAT2;ANGPTL3;ABCG8;APOC1;APOC3;PLTP;LIPG;ANGPTL4;CYP27A1;LCAT;CD36;PCSK9;LIPC;APOH;VAPB,combination
71,gsea,Purine metabolism,0.49503502660348836,2.2337184609584826,0.0,7.651710674343194e-05,0.003,37/103,32.83%,ALLC;PDE11A;NT5E;GUCY2F;ENTPD8;PDE6B;PDE2A;GDA;PDE6C;ADCY10;AK9;AK7;ADA;PDE9A;PDE1A;PDE6G;ADCY8;AK8;AMPD1;ENPP3;AMPD3;PDE4C;PDE1B;GUCY2D;ENTPD1;XDH;ADCY7;PDE3A;GUCY1A2;NPR2;ENPP1;PDE6A;ADCY5;NPR1;ADCY1;ADCY2;NME3,combination
72,gsea,Amino sugar and nucleotide sugar metabolism,0.572610264768426,2.216327473822946,0.0,0.00015093785439800273,0.006,10/41,21.95%,CHIT1;CYB5R2;HK2;GALK1;NPL;HKDC1;GFPT2;HK1;HK3;NANP,combination
73,gsea,Prion diseases,0.5970852275279871,2.2122580967458054,0.0,0.0001488981536628946,0.006,3/29,1.59%,C8A;C9;C7,combination
74,gsea,Basal transcription factors,0.6659597343255934,2.2104237545052032,0.0,0.00014691284494738934,0.006,2/33,2.92%,TAF7L;TBPL2,combination
75,gsea,Hypertrophic cardiomyopathy (HCM),0.5665158964660935,2.1982788574638144,0.0,0.00016914307806442847,0.007,33/77,28.92%,ITGA8;MYH6;MYBPC3;MYL2;ITGB7;PRKAG3;TNNT2;SGCG;CACNG5;CACNA1S;CACNG1;TNNI3;MYL3;ITGA11;MYH7;CACNG8;IGF1;ITGB4;CACNG6;SGCA;CACNG7;ITGA7;TTN;ITGA5;IL6;DES;CACNG3;RYR2;ACE;ACTC1;ITGB6;ITGA1;EDN1,combination
76,gsea,ABC transporters,0.6300070919364323,2.1926034225600737,0.0,0.00019079590252907703,0.008,13/35,22.96%,ABCA13;ABCG5;ABCC9;ABCA12;ABCG2;CFTR;ABCG8;ABCB5;ABCA9;ABCG4;ABCA4;ABCA6;ABCC2,combination
77,gsea,Tuberculosis,0.4480055497286562,2.19004246301224,0.0,0.0001883498012146017,0.008,43/122,38.12%,PLA2R1;CLEC4E;IFNG;NOS2;ATP6V0D2;IL12A;NOD2;ITGAM;IL10RA;MRC2;CAMP;CTSS;ITGAX;CIITA;SYK;TLR4;MRC1;IL10;IL1A;CAMK2A;LBP;TLR1;CD14;IL6;SPHK1;ATP6V0A4;CORO1A;CALML4;TIRAP;CYP27B1;TGFB1;BID;IL23A;C3;CAMK2G;IRAK4;CARD9;MAPK12;TGFB3;IL1B;KSR1;TNFRSF1A;MAPK11,combination
78,gsea,Ether lipid metabolism,0.6248036862710873,2.18649400355466,0.0,0.00020921132983014302,0.008,15/33,27.75%,PLA2G4D;PLA2G4E;PLA2G4F;PLD4;PLA2G5;PLA2G4C;PLA2G12B;ENPP6;PLA2G2C;PLA2G4A;LPCAT2;PLA2G7;PLD2;PLB1;PLA2G2D,combination
79,gsea,"Alanine, aspartate and glutamate metabolism",0.5787376278223755,2.1862704054377273,0.0,0.00020659618820726623,0.008,7/30,17.25%,FOLH1;CPS1;AGXT;GAD2;NAT8L;ASPA;GFPT2,combination
80,gsea,Protein digestion and absorption,0.6665001397050009,2.1861221166026845,0.0,0.00020404561798248517,0.008,33/66,22.18%,COL5A1;COL5A2;ATP1A4;COL5A3;CPA3;COL2A1;SLC8A3;COL4A6;MEP1B;KCNK5;COL4A3;COL17A1;ELN;COL6A2;SLC7A9;COL1A1;ATP1A2;SLC15A1;COL13A1;COL15A1;COL11A1;MME;COL9A1;KCNE3;XPNPEP2;COL6A5;COL6A1;COL12A1;KCNJ13;KCNN4;COL14A1;CPB2;COL4A5,combination
81,gsea,Mineral absorption,0.5806932696220521,2.183908601698288,0.0019120458891013384,0.00020155725678757682,0.008,16/32,32.91%,SLC26A9;ATP1A4;HEPH;ATP1A2;SLC34A2;SLC26A3;SLC5A1;TRPM6;CYBRD1;S100G;ATP1A3;SLC26A6;STEAP2;SLC46A1;FXYD2;SLC8A1,combination
82,gsea,Gap junction,0.47312486042570573,2.179352787477691,0.0,0.0001991288561033891,0.008,28/72,32.81%,PDGFRA;HTR2A;PRKG2;HTR2C;PDGFRB;PDGFD;CDK1;HTR2B;PLCB2;DRD2;TUBB1;EGF;GRM1;PDGFC;ADCY8;TUBB2B;SOS2;PRKG1;ADCY7;GRM5;GUCY1A2;GJA1;TUBA8;ADCY5;ADRB1;ADCY1;LPAR1;ADCY2,combination
83,gsea,Toll-like receptor signaling pathway,0.4947299497227182,2.175149584326669,0.0,0.00021862030498123408,0.009,14/72,24.17%,TLR8;IL12A;TLR7;IRF5;CD80;CXCL9;TLR5;TLR4;CD40;CD86;LBP;TLR1;CD14;IL6,combination
84,gsea,Arrhythmogenic right ventricular cardiomyopathy (ARVC),0.5318676294268813,2.174387728834954,0.0,0.0002160483013932196,0.009,20/65,24.85%,LEF1;ITGA8;ITGB7;SGCG;CACNG5;CACNA1S;CACNG1;ITGA11;TCF7;CTNNA3;CACNG8;ITGB4;CACNG6;SGCA;CACNG7;ITGA7;ITGA5;DES;CACNG3;RYR2,combination
85,gsea,Axon guidance,0.4503127204107407,2.16029020477275,0.0,0.0002562433342105628,0.011,64/159,37.48%,EPHB1;EPHA6;EPHA4;SHH;SEMA3D;EPHB4;BOC;SEMA5A;TRPC3;PLXNA4;NTNG2;ABLIM3;DCC;TRPC6;EPHA3;EFNA3;PLXNB3;RAC2;ROBO3;EFNB2;CAMK2A;SLIT3;SEMA5B;NTN1;SEMA3A;LRRC4C;TRPC5;CXCR4;BMP7;PLXNC1;EPHA8;RND1;EPHA5;SEMA3F;RHOD;ABLIM2;SEMA3G;SEMA6C;FES;UNC5D;PLXNA3;SEMA4G;PLCG2;SEMA6A;NTNG1;SEMA6B;SEMA4A;SEMA4D;NGEF;PARD6B;EPHB2;SLIT2;SMO;WNT5A;CXCL12;CAMK2G;TRPC4;SEMA4F;BMPR1B;PDK1;PIK3CD;EPHA2;SRGAP3;MYL9,combination
86,gsea,Central carbon metabolism in cancer,0.5078955305811593,2.151265376143072,0.0,0.0002955143432849785,0.013,20/52,36.80%,PGAM2;PDGFRA;FLT3;SLC16A3;PDGFRB;HK2;HKDC1;ERBB2;FGFR3;HK1;HK3;KIT;FGFR2;NTRK3;MTOR;SLC1A5;PFKL;PDK1;PIK3CD;NTRK1,combination
87,gsea,PPAR signaling pathway,0.6114284311863909,2.1506349868631793,0.0,0.0002921562257476492,0.013,27/60,26.00%,CYP7A1;OLR1;CYP8B1;RXRG;ACSBG2;ACOX2;SLC27A5;HMGCS2;PCK1;ADIPOQ;FABP1;PLIN1;CPT1B;PLIN4;PLIN5;APOC3;PLTP;FABP4;ANGPTL4;FABP6;FABP7;SLC27A6;SLC27A1;ACSBG1;CYP27A1;CD36;UCP1,combination
88,gsea,Drug metabolism,0.5497356158508848,2.149974441513133,0.0,0.0003095073980633202,0.014,13/57,23.79%,CYP1A2;MGST2;MPO;ALDH3A1;FMO3;CYP2E1;TYMP;UGT2A3;DPYS;ADH4;ADH7;TK1;FMO4,combination
89,gsea,AGE-RAGE signaling pathway in diabetic complications,0.4604124125616134,2.146621851790264,0.0,0.00032647298877197626,0.015,36/90,38.26%,MMP2;SELE;COL4A6;COL4A3;COL1A1;PLCD3;PLCD1;PLCB2;NOX1;IL1A;FN1;COL4A5;PLCE1;VCAM1;IL6;THBD;COL1A2;COL4A4;TGFBR2;NOX4;SMAD3;CCL2;EDN1;PLCG2;COL4A2;TGFB1;SERPINE1;PRKCD;TGFBR1;PLCD4;PIK3CD;MAPK12;TGFB3;IL1B;MAPK11;PIK3CB,combination
90,gsea,Hepatocellular carcinoma,0.4364482943201701,2.1465399683149675,0.0,0.00032288537351074574,0.015,46/136,36.18%,LEF1;WNT2;WNT8A;MGST2;WNT8B;WNT3A;WNT11;FZD10;IGF2;WNT2B;FZD4;TCF7;WNT6;WNT7A;SMARCD3;WNT16;WNT7B;CDK6;FZD9;NQO1;WNT9A;WNT10A;SHC3;SOS2;FZD2;TGFBR2;DPF1;AXIN2;WNT10B;FRAT2;SMAD3;DPF3;PLCG2;APC2;APC;MTOR;TGFB1;FZD1;RPS6KB2;TGFBR1;MGST1;WNT5A;FZD6;HGF;GSTO2;PIK3CD,combination
91,gsea,Morphine addiction,0.5275498757852076,2.1462816661374826,0.0,0.00031937574988562896,0.015,36/79,32.81%,GABRA1;GNGT1;GABRA6;GABRA2;PDE11A;GABRA3;GABRB2;OPRM1;PDE2A;GNB3;GNG8;GNG13;GABRQ;GABRP;GABRA5;PDE1A;GABRR1;GNG11;GNGT2;KCNJ5;ADCY8;GABRR2;GABRG2;GNG10;PDE4C;PDE1B;ADCY7;GABRA4;GABRD;PDE3A;ADCY5;GNG3;GABRE;ADCY1;GABRB1;ADCY2,combination
92,gsea,Small cell lung cancer,0.48983460561672904,2.137002441517075,0.0,0.00039492700254674547,0.018,33/83,39.04%,RXRG;LAMC3;BIRC7;NOS2;COL4A6;COL4A3;LAMB2;TRAF1;LAMA1;LAMA4;RARB;CDK6;FN1;COL4A5;LAMB3;PTGS2;SKP2;COL4A4;LAMB1;COL4A2;LAMA5;CDK2;MAX;LAMA3;ITGA2B;LAMA2;PIK3CD;ZBTB17;LAMC1;PIK3CB;E2F1;LAMC2;POLK,combination
93,gsea,Inflammatory bowel disease (IBD),0.6454712903194646,2.1349067941973994,0.0,0.0004102619340286138,0.019,18/43,19.51%,TBX21;IL21R;IFNG;IL12RB2;IL12A;IL2RG;NOD2;IL23R;IL21;IL18RAP;IL4;IL5;FOXP3;IL17A;TLR5;TLR4;IL10;IL1A,combination
94,gsea,HIF-1 signaling pathway,0.4537652078957748,2.134587236306079,0.0,0.00040594338735462843,0.019,32/83,36.18%,IFNG;EIF4E1B;EPO;NOS2;ANGPT1;IGF1;HK2;HKDC1;TLR4;TEK;ERBB2;EGF;CAMK2A;NPPA;HK1;HK3;TIMP1;EGLN3;IL6;FLT1;EDN1;PLCG2;MTOR;SERPINE1;ENO4;RPS6KB2;CAMK2G;INSR;PFKFB3;PFKL;PDK1;PIK3CD,combination
95,gsea,Type I diabetes mellitus,0.6677213173224654,2.1266276903536365,0.0,0.0004399733637747336,0.021,8/15,20.21%,PRF1;IFNG;IL12A;CD80;CD28;GAD2;IL1A;CD86,combination
96,gsea,Acute myeloid leukemia,0.49938043393595155,2.1217443556221207,0.0,0.00045436962354862684,0.022,15/56,31.28%,LEF1;MPO;FLT3;SPI1;CCNA1;TCF7;ITGAM;CEBPE;KIT;CD14;SOS2;RUNX1;MTOR;CSF1R;ZBTB16,combination
97,gsea,Bladder cancer,0.5656608934738165,2.1198369540983446,0.0,0.00044973319881853874,0.022,7/33,19.09%,MMP2;MMP9;TYMP;DAPK2;ERBB2;FGFR3;EGF,combination
98,gsea,Tyrosine metabolism,0.6129617921073715,2.119251412915607,0.0,0.0004451904392345131,0.022,11/29,24.54%,ALDH3A1;PNMT;TYRP1;TYR;DBH;HPD;HGD;ADH4;ADH7;AOC3;IL4I1,combination
99,gsea,Systemic lupus erythematosus,0.6888814347780088,2.1158176842989675,0.0,0.000440738534842168,0.022,12/26,20.21%,C8A;C9;CD40LG;C7;IFNG;CTSG;CD80;CD28;GRIN2B;IL10;CD40;CD86,combination
100,gsea,Basal cell carcinoma,0.6248720062102855,2.115038370801368,0.0,0.00043637478697244354,0.022,24/57,22.04%,LEF1;WNT2;WNT8A;HHIP;WNT8B;WNT3A;GLI1;WNT11;SHH;FZD10;KIF7;WNT2B;FZD4;TCF7;BMP4;WNT6;WNT7A;GLI2;WNT16;WNT7B;GLI3;FZD9;WNT9A;WNT10A,combination
101,gsea,Carbohydrate digestion and absorption,0.5603026105706657,2.108030677679861,0.003968253968253968,0.0004320966027864392,0.022,10/29,21.61%,ATP1A4;LCT;ATP1A2;HK2;PLCB2;HKDC1;HK1;GNAT3;SLC5A1;HK3,combination
102,gsea,Measles,0.4540299753439453,2.105357754959826,0.0,0.0004457307188937783,0.023,15/97,21.18%,CD3E;IL12A;TLR7;IL2RG;CD3G;IL2RA;CD28;OAS3;CD3D;TLR4;OAS2;IL1A;IL2RB;CDK6;CD46,combination
103,gsea,Renin secretion,0.5077283976638398,2.101174754302941,0.0,0.0004414448465967227,0.023,23/54,31.75%,CLCA2;ADRB3;ADCYAP1;PTGER2;CACNA1S;PRKG2;AQP1;PLCB2;CLCA1;PDE1A;NPPA;ADCYAP1R1;PDE1B;KCNJ2;ACE;CALML4;PDE3A;EDN1;GUCY1A2;EDNRA;ADCY5;NPR1;ADRB1,combination
104,gsea,Retrograde endocannabinoid signaling,0.4468090683835091,2.0976252364315253,0.001941747572815534,0.00043724060996246816,0.023,43/121,32.81%,GABRA1;GNGT1;GRIA4;SLC17A7;GABRA6;GRIA1;GABRA2;GABRA3;SLC17A6;GABRB2;CACNA1S;GNB3;GNG8;GNG13;GABRQ;GABRP;PLCB2;GABRA5;GABRR1;CNR1;GNG11;NDUFA4L2;GRM1;SLC17A8;GNGT2;KCNJ5;ADCY8;GABRR2;PTGS2;GABRG2;GNG10;ADCY7;MGLL;GABRA4;GABRD;GRM5;ADCY5;GRIA3;GNG3;GABRE;ADCY1;GABRB1;ADCY2,combination
105,gsea,Thyroid cancer,0.623881703654628,2.093046949873354,0.0,0.00043311569854772794,0.023,4/31,11.80%,LEF1;PAX8;RXRG;TCF7,combination
106,gsea,Thyroid hormone signaling pathway,0.5011871976212843,2.08180594497062,0.0,0.0005320441814683492,0.028,15/101,16.36%,MYH6;ATP1A4;DIO2;RXRG;PLN;PLCZ1;ATP1A2;SLCO1C1;BMP4;PLCD3;SLC16A2;ESR1;PLCD1;DIO3;PLCB2,combination
107,gsea,Glycosphingolipid biosynthesis,0.5796848665436707,2.069845960811277,0.0,0.0006291406554459959,0.031,11/37,25.78%,FUT7;FUT9;A4GALT;FUT2;A3GALT2;B3GNT5;B3GNT4;ST6GALNAC3;ST3GAL3;B4GALNT1;B3GNT2,combination
108,gsea,Glycosaminoglycan degradation,0.6605868964323651,2.063329007108092,0.0020161290322580645,0.0006570643294665347,0.033,2/18,7.50%,HYAL4;HPSE2,combination
109,gsea,Dilated cardiomyopathy (DCM),0.539496058407258,2.062720988346436,0.0,0.0006510910173804753,0.033,39/79,32.91%,ITGA8;MYH6;MYBPC3;MYL2;ITGB7;PLN;TNNT2;SGCG;CACNG5;CACNA1S;CACNG1;TNNI3;MYL3;ITGA11;MYH7;CACNG8;IGF1;ITGB4;CACNG6;SGCA;CACNG7;ITGA7;TTN;ADCY8;ITGA5;DES;CACNG3;RYR2;ACTC1;ITGB6;ADCY7;ITGA1;ADCY5;CACNB4;TGFB1;ADRB1;ADCY1;ADCY2;SLC8A1,combination
110,gsea,GnRH signaling pathway,0.4537778329297818,2.061038002670634,0.0,0.0006617695718350871,0.034,24/77,34.74%,MMP2;PLA2G4D;GNRHR;PLA2G4E;CGA;PLA2G4F;CACNA1S;PLA2G4C;PLCB2;PLA2G4A;CAMK2A;MMP14;ADCY8;SOS2;GNRH1;PLD2;ADCY7;CALML4;ADCY5;PRKCD;ADCY1;ADCY2;CACNA1F;CAMK2G,combination
111,gsea,Hedgehog signaling pathway,0.5008910463353039,2.0607098113460056,0.002028397565922921,0.0006558609149437023,0.034,12/40,27.52%,HHIP;LRP2;GLI1;SHH;KIF7;BOC;GLI2;GLI3;DHH;IHH;PTCH2;EVC,combination
112,gsea,Taste transduction,0.6398820191358795,2.049041738728323,0.0,0.0007475653614579544,0.04,24/41,29.54%,HTR3B;GABRA1;PKD2L1;GABRA6;GABRA2;P2RX2;GABRA3;KCNK5;GNB3;HTR1F;GNG13;HTR3A;GABRA5;PDE1A;GNAT3;P2RX3;GRM1;ADCY8;TAS1R1;SCNN1A;PDE1B;GRM4;GABRA4;SCN2A,combination
113,gsea,B cell receptor signaling pathway,0.4877734141227747,2.0446917802604694,0.0,0.0008376609580333602,0.046,14/60,25.90%,CD19;BTK;CARD11;RASGRP3;CR2;CD22;CD79B;SYK;RAC2;PIK3AP1;CD72;VAV1;SOS2;BLNK,combination
114,gsea,African trypanosomiasis,0.6673203316014428,2.042803819150041,0.0,0.000894252099679761,0.049,11/25,24.17%,SELE;IFNG;IL12A;IDO1;IDO2;PLCB2;LAMA4;IL10;NPPA;VCAM1;IL6,combination
115,gsea,Ovarian steroidogenesis,0.6470718177188355,2.0398597234775355,0.0,0.0009182052809211833,0.05,13/32,18.33%,FSHR;PLA2G4D;LHCGR;PLA2G4E;CYP19A1;CGA;CYP1B1;PLA2G4F;CYP17A1;PLA2G4C;IGF1;HSD17B2;PLA2G4A,combination
116,gsea,Cytokine-cytokine receptor interaction,0.6810432314196795,2.0384862326729465,0.0,0.0009103573725372416,0.05,105/185,22.74%,CXCR1;CCR4;CD40LG;IL24;OSM;IFNE;TNFRSF17;IL17B;TNFRSF8;IL22RA1;GDF5;IL19;BMP5;TNFSF11;CCR3;IL13RA2;CCR6;IL21R;CCL17;IFNG;TNFSF4;IL12RB2;XCR1;INHBC;EPO;IL12A;CXCR3;GDF6;CCL19;TNFSF8;IL2RG;IL15;NODAL;LEPR;CXCL17;IL31RA;TNFSF18;CD70;IL7R;TNFRSF18;PPBP;IL2RA;IL16;IL23R;IL21;IL5RA;LEP;ACKR4;IL18RAP;CXCR6;CSF3;IL17RB;GDF10;MSTN;IL4;AMH;BMP4;IL5;EDAR;IL10RA;IL17C;MPL;TNFRSF13B;CCL24;IL27;CXCL9;CX3CR1;IL31;CCR9;INHBE;CXCL14;IL34;CCR7;CD27;IL17A;IL33;TNFSF14;TNFRSF25;CCL20;GDF3;OSMR;NGFR;CD4;AMHR2;ACKR3;IL10;GDF9;TNFRSF1B;CXCR2;IL1A;GDF15;CD40;IL2RB;CLCF1;TNFRSF13C;EPOR;IL1RL2;ACVRL1;BMP3;NGF;CXCR4;CCL22;IL7;EDA;BMP7,combination
117,gsea,Primary immunodeficiency,0.7596105207188771,2.0371326488539427,0.0,0.0009182052809211832,0.051,20/30,20.35%,CD40LG;CD3E;CD8A;CD19;RAG1;BTK;IL2RG;AIRE;IL7R;TNFRSF13B;RAG2;CD3D;CIITA;AICDA;ADA;CD4;ICOS;CD40;UNG;TNFRSF13C,combination
118,gsea,ECM-receptor interaction,0.6122000739996734,2.036177645591966,0.0,0.0009104892701571396,0.051,41/74,29.27%,ITGA8;THBS2;LAMC3;TNC;COL2A1;GP1BA;COL4A6;ITGB7;COL4A3;COL6A2;LAMB2;LAMA1;COL1A1;ITGA11;TNN;THBS4;ITGB4;COL9A1;LAMA4;COL6A5;COL6A1;RELN;CHAD;ITGA7;FN1;VWF;SDC1;HMMR;COL4A5;LAMB3;ITGA5;VTN;HSPG2;CD36;COL1A2;COL4A4;ITGB6;THBS1;THBS3;ITGA1;LAMB1,combination
119,gsea,Primary bile acid biosynthesis,0.7313422312683604,2.0335215927327113,0.0,0.0009029018595724967,0.051,6/16,12.98%,CYP7A1;CYP8B1;ACOX2;SLC27A5;CH25H;BAAT,combination
120,gsea,Natural killer cell mediated cytotoxicity,0.4626909224288686,2.033017005875825,0.0,0.0008954398607330546,0.051,21/65,33.78%,PRF1;ITGAL;IFNG;KLRD1;CD48;SYK;RAC2;ICAM2;LCP2;SH3BP2;SHC3;VAV1;SOS2;CD247;LAT;PLCG2;TYROBP;BID;LCK;VAV2;VAV3,combination
121,gsea,Neuroactive ligand-receptor interaction,0.6805520785128139,2.026162151702139,0.0,0.0009182052809211833,0.052,152/253,23.29%,CHRNA2;PMCH;RXFP1;AVPR2;NTSR1;FSHR;CHRNA6;HRH4;NPY5R;GABRA1;CHRND;GNRHR;HCRTR2;GRM3;LHCGR;AVP;GRM7;P2RY10;TACR2;GRIA4;CHRNB3;GRM6;FPR1;LPAR3;GRIK1;CHRNA5;UTS2;ADRB3;GZMA;AGTR2;CTSG;NMU;ADCYAP1;HCRTR1;PTGFR;ADRA2B;GABRA6;PTGDR;PTH2R;OPRD1;CGA;LPAR4;HTR4;GLRA1;GRIA1;CHRM1;CHRNA1;GPR35;CHRNA9;GLRA2;GRM2;C5AR1;GHRHR;GABRA2;P2RX2;ADRA1D;LEPR;ADRA2C;P2RY13;NMUR1;P2RY2;HRH1;PTGER2;GABRA3;CALCR;INSL3;HTR2A;TAAR2;GABRB2;OPRM1;RXFP4;PTH;TACR1;PTGIR;CCKAR;CRH;CHRM5;TAC4;LEP;NTS;CYSLTR1;CHRNG;MTNR1B;HTR6;F2RL2;GLP2R;HTR2C;P2RX7;GRP;UCN;NTSR2;GRIN2B;ADM;P2RY6;HTR1F;GRIN3A;SCTR;SSTR5;TSHR;CCKBR;GRPR;CNR2;S1PR3;HTR2B;APLNR;GABRQ;GABRP;GPR156;DRD2;HTR7;HRH2;APLN;GABRA5;P2RY14;HTR5A;S1PR5;CALCRL;GIP;CHRNE;TRH;HRH3;DRD3;BDKRB1;CHRNB4;C3AR1;S1PR4;P2RX1;GABRR1;PTH1R;PTGER1;GRIN3B;CNR1;CALCB;P2RX3;F2RL3;ADCYAP1R1;TACR3;CHRNA3;NPY1R;CCK;GRM1;GRIN2D;PRLHR;GRID1;VIPR2;P2RX6;CHRNA10;NPFFR2;GABRR2;HCRT;PENK;CHRM2,combination
122,gsea,Pyruvate metabolism,0.58699777369771,2.0242744814930056,0.0,0.0009406005316753585,0.053,4/27,10.70%,LDHC;ACOT12;ACSS1;PCK1,combination
123,gsea,VEGF signaling pathway,0.4908986310142225,2.023081262202923,0.0,0.0009478248061121892,0.053,10/50,25.77%,PLA2G4D;PLA2G4E;PLA2G4F;SH2D2A;PLA2G4C;RAC2;KDR;PLA2G4A;PTGS2;SPHK1,combination
124,gsea,Cardiac muscle contraction,0.4508131443881513,2.0224808386649205,0.00196078431372549,0.0009549334921580306,0.054,24/65,33.38%,MYH6;ATP1A4;MYL2;TNNT2;CACNG5;CACNA1S;CACNG1;TNNI3;MYL3;ATP1A2;MYH7;CACNG8;CACNG6;COX4I2;CACNG7;CACNG3;RYR2;ACTC1;ATP1A3;CACNB4;COX6B2;FXYD2;SLC8A1;COX7B2,combination
125,gsea,Pentose phosphate pathway,0.6157695454053503,2.0071329276406193,0.0,0.0010931015249061704,0.059,4/21,21.99%,TKTL1;ALDOB;FBP2;RGN,combination
126,gsea,Glycosaminoglycan biosynthesis,0.5892715438489694,2.0069713807034253,0.0,0.0010844944262848619,0.059,18/51,29.31%,NDST3;CHST13;CHST4;HS3ST3A1;CHSY3;EXTL1;B3GNT7;HS3ST2;CHST3;CHSY1;HS3ST5;CHST1;CHST7;ST3GAL3;CHST2;B3GNT2;HS6ST2;CHST14,combination
127,gsea,Collecting duct acid secretion,0.6367093344464887,2.0041757818416084,0.0,0.001090368771093905,0.06,5/19,12.89%,ATP6V1E2;ATP6V0D2;SLC4A1;ATP6V1B1;ATP6V1C2,combination
128,gsea,Porphyrin and chlorophyll metabolism,0.6249048817372229,1.9973578276704929,0.005928853754940711,0.0011673307447370082,0.064,4/22,24.70%,HEPH;UGT2A3;ALAS2;CP,combination
129,gsea,Prostate cancer,0.4594258364506209,1.9868577971714796,0.0,0.001327866098562942,0.071,19/86,24.42%,LEF1;PDGFRA;MMP3;MMP9;NKX3-1;TCF7;PDGFRB;IGF1;PDGFD;AR;ERG;ERBB2;CREB3L4;EGF;PLAU;PDGFC;CREB3L3;SOS2;ETV5,combination
130,gsea,Arachidonic acid metabolism,0.6547343970619337,1.982619443125828,0.0,0.0013457665186020395,0.073,20/36,27.75%,PLA2G4D;ALOX12;PLA2G4E;ALOX15;PTGDS;GPX8;PLA2G4F;PLA2G5;CYP2E1;PLA2G4C;TBXAS1;PLA2G12B;PLA2G2C;PLA2G4A;PTGIS;PTGS1;PTGS2;PLB1;GGT5;PLA2G2D,combination
131,gsea,Glyoxylate and dicarboxylate metabolism,0.5816088284302514,1.9793667158787958,0.006198347107438017,0.001432956726286089,0.077,4/23,13.43%,HAO2;ACSS1;HAO1;AGXT,combination
132,gsea,Galactose metabolism,0.6039010284143368,1.9723127550541117,0.0039603960396039604,0.0016016813922835678,0.084,7/22,26.75%,LCT;HK2;GALK1;HKDC1;HK1;HK3;GALM,combination
133,gsea,Olfactory transduction,0.5342224039973322,1.9640550952117282,0.0,0.0016582513282307938,0.084,15/32,28.39%,ANO2;SLC8A3;CNGA3;PRKG2;PDE2A;SLC24A4;CNGA4;GNG13;PDE1A;CAMK2A;CNGB1;PRKG1;PDE1B;GUCY2D;CALML4,combination
134,gsea,Insulin secretion,0.43546434864689,1.9460868702983973,0.0021141649048625794,0.00197244097383069,0.096,26/75,34.74%,ATP1A4;ADCYAP1;KCNMB3;CACNA1S;CCKAR;ATP1A2;PLCB2;GIP;CREB3L4;CAMK2A;KCNN4;STX1A;ADCYAP1R1;CCK;CREB3L3;ADCY8;RYR2;ADCY7;ATP1A3;ADCY5;ADCY1;ADCY2;FXYD2;KCNMB4;CACNA1F;CAMK2G,combination
135,gsea,"Glycine, serine and threonine metabolism",0.6005459388421734,1.9446352172626458,0.0,0.0019984467878872815,0.097,13/34,29.66%,DMGDH;PGAM2;SDS;DAO;AGXT;SARDH;PIPOX;CHDH;ALAS2;AOC3;CTH;GLDC;AGXT2,combination
136,gsea,Nicotinate and nicotinamide metabolism,0.6329908130317643,1.944399693016089,0.0,0.0019972640417117707,0.097,8/23,24.05%,BST1;NT5E;NNMT;QPRT;ASPDH;NMRK2;CD38;ENPP3,combination
137,gsea,Peroxisome,0.4508821432429151,1.9423407048904422,0.0,0.0020360204055208846,0.098,24/74,38.54%,HAO2;NOS2;ACOX2;DAO;HAO1;BAAT;AGXT;FAR2;PIPOX;XDH;CAT;GSTK1;ABCD4;EPHX2;PEX26;ACOX3;HACL1;ACSL3;MPV17L2;PXMP2;SLC27A2;ACSL1;PEX5L;PAOX,combination
138,gsea,Chagas disease (American trypanosomiasis),0.4170938761212898,1.9422251303413713,0.0019880715705765406,0.002034584363480032,0.098,38/84,42.52%,CD3E;IFNG;NOS2;IL12A;CD3G;CD3D;PLCB2;TLR4;IL10;GNA15;IL6;CD247;C1QB;ACE;TGFBR2;SMAD3;CCL2;TGFB1;SERPINE1;C1QC;ADCY1;TGFBR1;C3;GNA14;IRAK4;PIK3CD;MAPK12;TGFB3;IL1B;TNFRSF1A;MAPK11;PIK3CB;MAPK9;PPP2R2B;GNAL;PIK3R3;FAS;TGFB2,combination
139,gsea,Hepatitis C,0.4314670408626308,1.9323242430559122,0.0,0.002216809892509714,0.103,23/114,31.09%,CLDN19;CLDN16;IFNG;CLDN18;CLDN14;CLDN10;CLDN4;OAS3;CLDN5;CLDN15;OAS2;CLDN8;EGF;CDK6;CLDN11;SOS2;CLDN2;CLDN9;MAVS;PPARA;EIF2AK4;BID;CDK2,combination
140,gsea,Mucin type O-glycan biosynthesis,0.6246213664089075,1.9308529565255426,0.0,0.0022401604016800496,0.104,12/25,30.85%,GALNT15;ST6GALNAC1;GALNT6;GALNTL5;GALNTL6;GCNT3;B3GNT6;GALNT16;GALNT5;GCNT4;GALNT7;GALNT2,combination
141,gsea,Starch and sucrose metabolism,0.6030119172385048,1.9164954474162468,0.0019011406844106464,0.0024830339991108053,0.114,9/21,29.61%,TREH;HK2;HKDC1;PYGM;HK1;HK3;ENPP3;PYGL;ENPP1,combination
142,gsea,Phototransduction,0.5803441400033145,1.9134993316692184,0.0,0.002568406380199114,0.117,13/20,30.48%,GNGT1;GUCY2F;PDE6B;CNGA1;RHO;PDE6G;CNGB1;SLC24A1;GUCY2D;CALML4;GNAT1;PDE6A;GUCA1B,combination
143,gsea,Necroptosis,0.44206354579760215,1.9104334239245622,0.002044989775051125,0.0026270873315244964,0.118,16/97,24.68%,PLA2G4D;PLA2G4E;IFNG;ALOX15;PLA2G4F;ZBP1;PLA2G4C;IL33;TLR4;PLA2G4A;PYGM;IL1A;CAMK2A;SLC25A31;STAT4;MLKL,combination
144,gsea,Estrogen signaling pathway,0.42678481149760233,1.9039473865435739,0.0,0.0027482833925503002,0.12,28/98,32.81%,KRT24;MMP2;KRT26;KRT14;OPRM1;MMP9;ESR2;TFF1;PGR;KRT15;ESR1;PLCB2;KRT27;CREB3L4;KRT17;GRM1;SHC3;CREB3L3;KCNJ5;ADCY8;SOS2;GPER1;ADCY7;CALML4;ADCY5;PRKCD;ADCY1;ADCY2,combination
145,gsea,Arginine biosynthesis,0.5881962039967487,1.8980396748939097,0.0019305019305019305,0.002817506615429384,0.122,5/17,21.15%,NOS2;CPS1;NOS1;ARG2;NAGS,combination
146,gsea,Vasopressin-regulated water reabsorption,0.5438899880472148,1.8972498355732454,0.0,0.0027983399037597965,0.122,6/36,22.39%,AVPR2;AVP;AQP3;CREB3L4;ARHGDIB;CREB3L3,combination
147,gsea,Steroid hormone biosynthesis,0.7013681150026655,1.8921986014381187,0.0019569471624266144,0.0029159221758983524,0.128,14/22,24.63%,CYP7A1;CYP1A2;CYP19A1;SULT1E1;CYP1B1;CYP2E1;CYP17A1;HSD17B6;HSD11B1;UGT2A3;HSD17B2;HSD17B3;HSD11B2;HSD17B1,combination
148,gsea,Pyrimidine metabolism,0.4686642129775039,1.8878555569812967,0.003937007874015748,0.0030072763563056206,0.132,16/47,41.42%,NT5E;TYMP;ENTPD8;AK9;DPYS;TK1;DCTD;ENPP3;ENTPD1;ENPP1;NME3;NME6;UPRT;ENTPD5;RRM2;DPYD,combination
149,gsea,mTOR signaling pathway,0.4228452053526897,1.887739399469348,0.0,0.002987227847263583,0.132,26/132,27.74%,WNT2;WNT8A;ATP6V1E2;EIF4E1B;WNT8B;WNT3A;WNT11;FZD10;ATP6V1B1;WNT2B;FZD4;WNT6;WNT7A;ATP6V1C2;IGF1;WNT16;WNT7B;FZD9;WNT9A;WNT10A;SOS2;SKP2;FZD2;PRR5;WNT10B;TBC1D7,combination
150,gsea,beta-Alanine metabolism,0.5343944398328956,1.8804536257519857,0.0039603960396039604,0.0031863547496867556,0.138,7/29,26.08%,ALDH3A1;GAD2;GADL1;DPYS;CNDP1;AOC3;SMOX,combination
151,gsea,Regulation of lipolysis in adipocytes,0.4871511031606734,1.8789427814786994,0.0,0.003213718483224141,0.141,20/45,32.81%,ADRB3;CGA;PRKG2;PLIN1;TSHR;FABP4;NPPA;NPY1R;ADCY8;PTGS1;PTGS2;PTGER3;PRKG1;ADCY7;MGLL;ADCY5;NPR1;ADRB1;ADCY1;ADCY2,combination
152,gsea,Cytosolic DNA-sensing pathway,0.513016977217172,1.8748236700068608,0.005870841487279843,0.0032767325711304967,0.144,7/33,27.99%,TREX1;AIM2;ZBP1;IL33;IL6;POLR3B;MAVS,combination
153,gsea,Phenylalanine metabolism,0.6315152852334629,1.8700448142820054,0.013806706114398421,0.003422401501615319,0.146,6/15,24.54%,ALDH3A1;PAH;HPD;GLYAT;AOC3;IL4I1,combination
154,gsea,Cysteine and methionine metabolism,0.5015808537780417,1.866188351162493,0.00199203187250996,0.0034951039725386974,0.147,8/36,29.66%,LDHC;SDS;BHMT2;BCAT1;IL4I1;CTH;BCAT2;AGXT2,combination
155,gsea,Cocaine addiction,0.4710927367994433,1.8613525391111279,0.00411522633744856,0.0036492773985329074,0.151,12/44,25.47%,GRM3;GRM2;GRIN2B;GRIN3A;PPP1R1B;DRD2;CREB3L4;GRIN3B;GRIN2D;CREB3L3;SLC18A2;GRIN2A,combination
156,gsea,Propanoate metabolism,0.5895025281382924,1.853184371235714,0.00816326530612245,0.0038950618923153375,0.159,3/26,19.55%,LDHC;ACSS1;ACSS3,combination
157,gsea,RIG-I-like receptor signaling pathway,0.5004519171430044,1.8492580048725067,0.00784313725490196,0.004056375228373329,0.162,2/43,5.51%,IFNE;IL12A,combination
158,gsea,TNF signaling pathway,0.41273162295744964,1.8440958705734196,0.005905511811023622,0.004296507729593462,0.171,33/93,42.36%,SELE;MMP3;IL15;MMP9;NOD2;TRAF1;CCL20;TNFRSF1B;CREB3L4;CREB3L3;MMP14;VCAM1;PTGS2;IL6;MLKL;IL18R1;LIF;CCL2;EDN1;JAG1;DAB2IP;PIK3CD;MAPK12;IL1B;CASP7;TNFRSF1A;MAPK11;PIK3CB;RPS6KA5;MAPK9;MAP2K6;PIK3R3;FAS,combination
159,gsea,Amyotrophic lateral sclerosis (ALS),0.4638084623396039,1.8402497434442682,0.0057251908396946565,0.004395907782410165,0.178,15/40,38.12%,GRIA1;PRPH;GRIN2B;NOS1;SLC1A2;TNFRSF1B;GRIN2D;GRIN2A;CAT;BID;GRIN2C;MAPK12;NEFH;TNFRSF1A;MAPK11,combination
160,gsea,Linoleic acid metabolism,0.7452855876714456,1.8251980947711608,0.0,0.0049275115696639895,0.193,11/17,18.33%,PLA2G4D;PLA2G4E;CYP1A2;ALOX15;PLA2G4F;PLA2G5;CYP2E1;PLA2G4C;PLA2G12B;PLA2G2C;PLA2G4A,combination
161,gsea,Osteoclast differentiation,0.3920616986993773,1.8218572180976034,0.004149377593360996,0.005033125243567967,0.197,41/96,42.52%,TNFSF11;IFNG;BTK;SPI1;CALCR;NCF4;ACP5;NCF2;SYK;NOX1;NCF1;IL1A;LCP2;SOCS1;BLNK;TREM2;TGFBR2;CTSK;PLCG2;TYROBP;TGFB1;CSF1R;LCK;TGFBR1;STAT2;PIK3CD;MAPK12;IL1B;MITF;TNFRSF1A;MAPK11;PIK3CB;TEC;CAMK4;CYBA;PPARG;MAPK9;MAP2K6;FYN;PIK3R3;TGFB2,combination
162,gsea,Hematopoietic cell lineage,0.6710242273836051,1.803996424106718,0.0,0.005914819294277561,0.22,36/55,26.80%,MS4A1;CD3E;DNTT;CD8A;CD19;EPO;FLT3;GP1BA;CD5;CD3G;CD37;IL7R;IL2RA;IL5RA;CR2;CSF3;IL4;CD22;ITGAM;IL5;CD7;CD3D;MME;CD4;CD2;IL1A;CD38;EPOR;IL7;ITGA5;KIT;CD14;IL6;CD36;CD34;CSF3R,combination
163,gsea,Malaria,0.6466654221991345,1.7981111935988723,0.0,0.00620348445890653,0.225,20/33,28.87%,CD40LG;GYPC;SELE;ITGAL;IFNG;THBS2;IL12A;CSF3;SELP;THBS4;TLR4;IL10;CD40;SDC1;VCAM1;IL6;CD36;THBS1;THBS3;CCL2,combination
164,gsea,Cell cycle,0.3953083499710031,1.7972439922546894,0.002028397565922921,0.0062215363883023215,0.226,43/111,43.82%,BUB1;CCNB3;CDC25C;CCNB1;CCNA1;CDC20;TTK;CDK1;BUB1B;SMC1B;CDC25B;ESPL1;CDK6;CCNB2;ORC1;CCNA2;PLK1;SKP2;MCM3;CDC6;MCM5;RBL1;SMAD3;TGFB1;CDK2;CHEK2;ZBTB17;SFN;TGFB3;CDC7;E2F1;MCM6;MCM4;DBF4;MAD2L1;CCNE1;PCNA;PKMYT1;TGFB2;MCM7;CCNE2;CHEK1;MAD1L1,combination
165,gsea,Nicotine addiction,0.6580248752716849,1.7929412752305707,0.0,0.006460625109132181,0.232,22/37,25.47%,CHRNA6;GABRA1;GRIA4;SLC17A7;GABRA6;GRIA1;GABRA2;GABRA3;SLC17A6;GABRB2;GRIN2B;GRIN3A;GABRQ;GABRP;GABRA5;GABRR1;GRIN3B;GRIN2D;SLC17A8;GABRR2;GABRG2;GRIN2A,combination
166,gsea,alpha-Linolenic acid metabolism,0.6674362937506658,1.783516804050087,0.001953125,0.006850801078010744,0.242,8/17,18.33%,PLA2G4D;PLA2G4E;PLA2G4F;PLA2G5;PLA2G4C;PLA2G12B;PLA2G2C;PLA2G4A,combination
167,gsea,Human T-cell leukemia virus 1 infection,0.378199002059285,1.7811704066336989,0.003875968992248062,0.006886539606908874,0.244,54/171,42.52%,CD3E;TBPL2;ITGAL;SPI1;IL2RG;IL15;CD3G;CCNA1;IL2RA;MMP7;CDC20;CD3D;BUB1B;CD4;CREB3L4;ESPL1;CD40;IL2RB;TNFRSF13C;CCNB2;CCNA2;CREB3L3;ADCY8;SLC25A31;IL6;TGFBR2;ADCY7;SMAD3;TLN2;ADCY5;TGFB1;CDK2;ETS1;ADCY1;CHEK2;LCK;ADCY2;TGFBR1;MSX1;PIK3CD;EGR2;TGFB3;TNFRSF1A;PIK3CB;E2F1;NRP1;IL15RA;MAD2L1;CCNE1;MAPK9;IL1R2;NFYB;PIK3R3;TGFB2,combination
168,gsea,Fluid shear stress and atherosclerosis,0.3726609226386047,1.777960532617633,0.00597609561752988,0.007019652206805732,0.251,41/111,41.64%,MMP2;SELE;IFNG;MGST2;MMP9;TRPV4;BMP4;NPPC;NCF2;CAV3;NOX1;NCF1;RAC2;KDR;IL1A;SDC1;NQO1;VCAM1;THBD;ASS1;CDH5;CALML4;CCL2;EDN1;CAV1;ITGA2B;MGST1;CAV2;BMPR1B;GSTO2;PIK3CD;MAPK12;IL1B;TNFRSF1A;MAPK11;PIK3CB;PDGFB;CYBA;MAPK9;MAP2K6;IL1R2,combination
169,gsea,Pantothenate and CoA biosynthesis,0.5919044790355765,1.7662517530212092,0.003875968992248062,0.007658912284389634,0.265,8/16,29.80%,GADL1;DPYS;ENPP3;BCAT1;VNN1;BCAT2;ENPP1;PANK2,combination
170,gsea,Chemical carcinogenesis,0.6318490395487837,1.7536606704451916,0.0,0.008247738663713085,0.281,10/24,24.05%,CYP1A2;MGST2;ALDH3A1;CYP1B1;CYP2E1;HSD11B1;UGT2A3;ADH4;ADH7;PTGS2,combination
171,gsea,Histidine metabolism,0.5783292755255208,1.7521417655743792,0.005703422053231939,0.008263847528290649,0.281,7/19,25.70%,ALDH3A1;FTCD;HAL;ASPA;UROC1;CNDP1;AMDHD1,combination
172,gsea,Vitamin digestion and absorption,0.6193900416563548,1.7503495404090819,0.001937984496124031,0.008322230523031302,0.285,5/19,16.88%,FOLH1;CUBN;LRAT;SLC19A3;SLC23A1,combination
173,gsea,Complement and coagulation cascades,0.6303678119526893,1.7444068041956302,0.0,0.008612132290019375,0.296,39/53,33.58%,C8A;C9;SERPINA5;C7;A2M;C5AR1;SERPINB2;KLKB1;CR2;F2RL2;F11;F10;ITGAM;VSIG4;FGB;ITGAX;PROCR;FGG;BDKRB1;C3AR1;PLAU;F2RL3;CD46;VWF;CPB2;F7;VTN;C1QB;THBD;MASP2;F12;C6;SERPINE1;C1QC;PLAUR;PROS1;SERPINC1;SERPIND1;C3,combination
174,gsea,Prolactin signaling pathway,0.4681167760315128,1.7406925922348342,0.0020408163265306124,0.008846252020760658,0.305,10/59,24.39%,LHCGR;TNFSF11;CGA;ELF5;ESR2;CYP17A1;ESR1;SHC3;SOS2;SOCS1,combination
175,gsea,Antigen processing and presentation,0.51758608648463,1.74040419122423,0.013725490196078431,0.008806423376107712,0.305,6/24,18.09%,CD8A;IFNG;KLRD1;CTSS;CIITA;CD4,combination
176,gsea,Fat digestion and absorption,0.5949692250992901,1.7362138331990828,0.001953125,0.009026424795496377,0.311,12/24,32.30%,ABCG5;MOGAT2;PLA2G5;ABCG8;FABP1;PLA2G12B;PLA2G2C;NPC1L1;CD36;PLA2G2D;DGAT2;APOA1,combination
177,gsea,Epstein-Barr virus infection,0.3845759207223207,1.73501406056066,0.004024144869215292,0.009047932936717728,0.313,43/143,42.36%,CD3E;CD19;ITGAL;BTK;CD3G;CCNA1;CR2;ENTPD8;OAS3;RUNX3;CD3D;SYK;OAS2;CD40;CDK6;RBPJL;CCNA2;VIM;IL6;SKP2;CD247;BLNK;ENTPD1;MAVS;PLCG2;BID;CDK2;STAT2;IRAK4;PIK3CD;MAPK12;LYN;ISG15;MAPK11;PIK3CB;E2F1;POLK;CIR1;CCNE1;MAPK9;MAP2K6;PIK3R3;FAS,combination
178,gsea,Aldosterone synthesis and secretion,0.37828025110139896,1.7325465267624705,0.010040160642570281,0.009182052809211833,0.315,24/80,34.74%,ATP2B3;ATP1A4;CACNA1S;PDE2A;ATP1A2;PLCB2;CREB3L4;CAMK2A;NPPA;CREB3L3;KCNJ5;ADCY8;KCNK9;PRKD2;CACNA1G;ADCY7;CALML4;ATP1A3;ADCY5;NPR1;ADCY1;ADCY2;CACNA1F;CAMK2G,combination
179,gsea,Alcoholism,0.40296650546088864,1.7320774190783885,0.0019455252918287938,0.009182052809211833,0.315,24/90,31.55%,GNGT1;CRH;GNB3;GRIN2B;GRIN3A;GNG8;PPP1R1B;GNG13;DRD2;CREB3L4;GRIN3B;GNG11;GRIN2D;SHC3;GNGT2;CREB3L3;SOS2;SLC18A2;CAMKK2;GNG10;GRIN2A;CALML4;ADCY5;GNG3,combination
180,gsea,Sphingolipid signaling pathway,0.4200831335057814,1.7270214519849194,0.0,0.009547305738639043,0.322,28/101,43.72%,ACER1;CERS3;SPTLC3;MS4A2;OPRD1;S1PR3;PLCB2;RAC2;S1PR5;S1PR4;PLD2;SPHK1;S1PR1;BID;ADORA3;PIK3CD;MAPK12;TNFRSF1A;MAPK11;PIK3CB;PRKCG;MAPK9;PPP2R2B;FYN;PIK3R3;PPP2R5D;TRAF2;PLD1,combination
181,gsea,AMPK signaling pathway,0.3822646901054525,1.718547718593177,0.007889546351084813,0.010140618761821858,0.331,26/104,36.18%,PRKAG3;LEPR;CCNA1;LEP;PCK1;ADIPOQ;CFTR;CPT1B;IGF1;CREB3L4;FBP2;CCNA2;CREB3L3;CAMKK2;CD36;PFKFB4;PFKFB1;MTOR;RPS6KB2;ACACB;ADRA1A;INSR;PFKFB3;GYS2;PFKL;PIK3CD,combination
182,gsea,Fructose and mannose metabolism,0.5329506828290411,1.7174902930896156,0.011673151750972763,0.010195590878862537,0.334,10/22,35.73%,HK2;HKDC1;ALDOB;HK1;FBP2;HK3;PFKFB4;PFKFB1;PFKFB3;PFKL,combination
183,gsea,Mannose type O-glycan biosynthesis,0.5797589525008566,1.7136036664956105,0.019646365422396856,0.010489497285306125,0.34,4/16,25.25%,FUT9;B3GAT1;ST3GAL3;MGAT5B,combination
184,gsea,Glycerolipid metabolism,0.45800431611355835,1.7053816450698802,0.011741682974559686,0.01109787571967441,0.35,12/38,31.71%,MOGAT2;LIPG;GPAT2;MOGAT1;GPAM;PNPLA3;LPIN3;DGKI;LIPC;MGLL;LCLAT1;DGAT2,combination
185,gsea,Oocyte meiosis,0.38745364748899763,1.7038528276971991,0.01,0.011186307347136566,0.353,25/92,32.81%,BUB1;CDC25C;CCNB1;PLCZ1;PGR;STAG3;CDC20;IGF1;CDK1;AR;SMC1B;CAMK2A;ESPL1;CCNB2;FBXO43;ADCY8;PLK1;ADCY7;CALML4;AURKA;ADCY5;CDK2;ADCY1;SPDYA;ADCY2,combination
186,gsea,Metabolism of xenobiotics by cytochrome P450,0.6275588926668518,1.7024745984421585,0.0,0.011214870917775307,0.353,9/25,20.73%,CYP1A2;MGST2;ALDH3A1;CYP1B1;CYP2E1;HSD11B1;UGT2A3;ADH4;ADH7,combination
187,gsea,p53 signaling pathway,0.4053119632753195,1.6954511180164302,0.009689922480620155,0.01180968281525224,0.362,24/59,43.82%,SERPINB5;CCNB1;IGF1;CDK1;PMAIP1;GTSE1;CDK6;CCNB2;STEAP3;THBS1;RPRM;BID;CDK2;SERPINE1;CHEK2;IGFBP3;SFN;RRM2;CCNE1;FAS;ZMAT3;CCNE2;GORAB;CHEK1,combination
188,gsea,Staphylococcus aureus infection,0.66218904846577,1.6932284919308447,0.0,0.011951243338974132,0.363,13/19,27.73%,FPR1;ITGAL;C5AR1;SELPLG;ITGAM;CAMP;SELP;FGG;IL10;C3AR1;PTAFR;C1QB;MASP2,combination
189,gsea,Insulin resistance,0.38597708267195496,1.6927389389407037,0.014522821576763486,0.011936668651975383,0.365,31/93,38.26%,PRKAG3;PPP1R3A;SLC27A5;PCK1;CPT1B;PRKCQ;GFPT2;CREB3L4;PYGM;SLC27A6;CREB3L3;SLC27A1;IL6;PPARGC1B;CD36;PPP1R3D;PYGL;PPARA;PPP1R3E;MTOR;PPP1R3C;PRKCD;RPS6KB2;ACACB;INSR;GYS2;PIK3CD;TBC1D4;SLC27A2;TNFRSF1A;PIK3CB,combination
190,gsea,Inositol phosphate metabolism,0.4094519644722885,1.6788113207059645,0.01609657947686117,0.013172159527351006,0.389,21/67,43.39%,PLCZ1;MIOX;PLCD3;PLCD1;INPP4B;PLCB2;PIK3CG;IMPA2;PIP5KL1;PLCE1;INPP5J;PLCG2;PIK3C2B;PLCD4;PLCH1;PIK3CD;PIK3CB;MTMR4;PIK3C2G;SYNJ2;ITPKA,combination
191,gsea,Protein export,-0.890260262338948,-1.6727646445463862,0.0,0.2390691114245416,0.401,14/19,4.34%,HSPA5;SEC61G;SEC61B;SPCS2;SRP9;SEC11C;SEC62;SPCS1;SEC61A1;SRP72;SRP14;SEC11A;SEC63;IMMP1L,combination
192,gsea,Progesterone-mediated oocyte maturation,0.3720867782589876,1.6496717443869289,0.021956087824351298,0.016307708374693933,0.446,25/78,38.26%,BUB1;CCNB3;CDC25C;CCNB1;CCNA1;PGR;IGF1;CDK1;CDC25B;CCNB2;CCNA2;ADCY8;PLK1;ADCY7;AURKA;ADCY5;CDK2;ADCY1;SPDYA;ADCY2;PIK3CD;STK10;MAPK12;MAPK11;PIK3CB,combination
193,gsea,Influenza A,0.37340214271913086,1.649259731482345,0.00823045267489712,0.016261272798904686,0.447,42/110,47.20%,IFNG;TMPRSS13;IL12A;TLR7;NXF3;PABPN1L;OAS3;CIITA;IL33;TLR4;OAS2;IL1A;IL6;MAVS;CCL2;EIF2AK4;NLRP3;STAT2;IRAK4;PIK3CD;MAPK12;IL1B;RNASEL;PABPN1;TNFRSF1A;MAPK11;CPSF4;PIK3CB;MAPK9;MAP2K6;EIF2AK3;TMPRSS2;PIK3R3;FAS;TNFSF10;EIF2AK1;MAP2K1;TLR3;NXT1;NLRX1;RSAD2;MYD88,combination
194,gsea,Aldosterone-regulated sodium reabsorption,0.4235317917797454,1.641441987586411,0.03578528827037773,0.016982064680129926,0.461,14/33,38.26%,ATP1A4;KCNJ1;ATP1A2;IGF1;HSD11B2;SCNN1A;ATP1A3;FXYD4;FXYD2;INSR;PIK3CD;SFN;SGK1;PIK3CB,combination
195,gsea,Dopaminergic synapse,0.37659370126161246,1.634333240006258,0.003929273084479371,0.017808473704840587,0.482,25/109,31.55%,GNGT1;GRIA4;GRIA1;GNB3;GRIN2B;GNG8;PPP1R1B;GNG13;PLCB2;DRD2;DRD3;CREB3L4;CAMK2A;SCN1A;GNG11;GNGT2;CREB3L3;KCNJ5;SLC18A2;GNG10;GRIN2A;CALML4;ADCY5;GRIA3;GNG3,combination
196,gsea,Steroid biosynthesis,0.5334268360888537,1.6306742403174854,0.044921875,0.018148608460656447,0.488,3/16,19.82%,CYP24A1;SOAT2;CYP2R1,combination
197,gsea,Retinol metabolism,0.6896257963204326,1.6248848850018576,0.0,0.018774268383505207,0.498,17/22,27.26%,RPE65;CYP26C1;RDH8;CYP1A2;LRAT;ALDH1A2;DHRS9;SDR16C5;HSD17B6;CYP26A1;UGT2A3;ADH4;ADH7;RDH12;CYP26B1;DHRS3;CYP2S1,combination
198,gsea,Autoimmune thyroid disease,0.777518468163797,1.6180241513920086,0.0,0.019504906118962103,0.505,13/15,20.21%,CD40LG;PRF1;TG;CGA;CD80;CD28;IL4;IL5;CTLA4;TSHR;IL10;CD40;CD86,combination
199,gsea,Fanconi anemia pathway,0.4795065469706651,1.6103626515022076,0.002008032128514056,0.02040353644338428,0.517,25/44,43.36%,FANCA;EME1;FANCI;PALB2;RMI2;POLN;FANCD2;BRIP1;FANCG;UBE2T;BRCA2;POLI;FANCB;FANCL;RPA2;RAD51;FANCC;TELO2;REV1;POLK;PMS2;BRCA1;MLH1;ERCC1;EME2,combination
200,gsea,FoxO signaling pathway,0.3604425910074537,1.6068002212215813,0.012195121951219513,0.02080653166567401,0.52,35/115,38.57%,RAG1;CCNB3;PRKAG3;IL7R;CCNB1;PCK1;RAG2;IGF1;IL10;EGF;S1PR4;CCNB2;GRM1;HOMER2;SOS2;PLK1;IL6;SKP2;TGFBR2;S1PR1;SMAD3;CAT;TGFB1;CDK2;HOMER3;AGAP2;TGFBR1;INSR;PIK3CD;MAPK12;TGFB3;SGK1;MAPK11;PIK3CB;PLK2,combination
201,gsea,Maturity onset diabetes of the young,0.5527024535465503,1.603937332863342,0.03285420944558522,0.02118724424334551,0.528,2/22,3.25%,ONECUT1;PAX4,combination
202,gsea,Cortisol synthesis and secretion,0.38754477721601294,1.602981992919338,0.024539877300613498,0.021236906299325585,0.533,16/51,34.71%,CACNA1S;CYP17A1;MRAP;PLCB2;NR0B1;CREB3L4;CREB3L3;ADCY8;CACNA1G;ADCY7;KCNA4;KCNK2;ADCY5;ADCY1;ADCY2;CACNA1F,combination
203,gsea,NOD-like receptor signaling pathway,0.34876697647632915,1.5982710477512716,0.019569471624266144,0.02190123138039591,0.543,34/112,39.67%,NLRP12;NOD2;PSTPIP1;AIM2;P2RX7;MEFV;CAMP;OAS3;NLRP6;PLCB2;TLR4;OAS2;ANTXR2;IL6;TRPV2;MAVS;TANK;TRIP6;CCL2;NLRC4;ANTXR1;PRKCD;NLRP3;STAT2;IRAK4;CARD9;PANX1;MAPK12;IL1B;RNASEL;MAPK11;CASR;TRPM2;CYBA,combination
204,gsea,Intestinal immune network for IgA production,0.6648399303639367,1.5862657986997788,0.0,0.02350425478907068,0.566,17/28,22.07%,CD40LG;TNFRSF17;ITGB7;IL15;CD80;CD28;IL4;IL5;TNFRSF13B;CCR9;AICDA;ICOS;IL10;CD40;CD86;TNFRSF13C;CXCR4,combination
205,gsea,Salmonella infection,0.40634617057266087,1.5848336032421129,0.008368200836820083,0.023622510495504002,0.568,14/63,29.60%,IFNG;NOS2;PKN3;WAS;TLR5;TLR4;PFN4;FLNC;IL1A;LBP;CD14;IL6;NLRC4;DYNC1I1,combination
206,gsea,Glutathione metabolism,0.4314313180851975,1.5839137141040809,0.03977272727272727,0.023605898872614498,0.571,13/38,43.54%,MGST2;GPX8;GGT6;GGT5;GSTK1;MGST1;GSTO2;ANPEP;OPLAH;RRM2;HPGDS;GPX7;GSTM4,combination
207,gsea,Human immunodeficiency virus 1 infection,0.35768767985081434,1.5643979345883317,0.008602150537634409,0.026942893122295978,0.607,45/153,43.82%,CD3E;GNGT1;CCNB3;CD3G;CDC25C;CCNB1;GNB3;GNG8;CD3D;CDK1;GNG13;TLR4;RAC2;CD4;TNFRSF1B;GNG11;CCNB2;CXCR4;GNGT2;CD247;GNG10;CALML4;PLCG2;MTOR;BID;GNG3;RPS6KB2;IRAK4;PIK3CD;MAPK12;AP1G2;TNFRSF1A;MAPK11;PIK3CB;AP1B1;GNG7;PRKCG;MAPK9;MAP2K6;AP1M1;PIK3R3;FAS;TRAF2;PAK1;CHEK1,combination
208,gsea,Fc gamma R-mediated phagocytosis,0.3585661917447004,1.5612027272093694,0.027131782945736434,0.02742255387058842,0.617,33/74,44.02%,PLA2G4E;DOCK2;WAS;HCK;SYK;NCF1;RAC2;PLA2G4A;VAV1;PLD2;SPHK1;WASF3;LAT;PLCG2;PRKCD;RPS6KB2;VAV2;VAV3;ASAP1;PIK3CD;MYO10;LYN;PIK3CB;VASP;PRKCG;WASF1;SCIN;PIK3R3;PAK1;GSN;PLD1;ASAP2;MARCKSL1,combination
209,gsea,Pertussis,0.3730529809272423,1.5556381690037449,0.027777777777777776,0.028257877353516984,0.629,22/55,38.12%,NOS2;IL12A;ITGAM;TLR4;IL10;IL1A;ITGA5;CD14;IL6;C1QB;IRF8;CALML4;TIRAP;IL23A;C1QC;NLRP3;C3;IRAK4;MAPK12;IL1B;CASP7;MAPK11,combination
210,gsea,Ribosome,-0.7610774394737233,-1.5476116160558113,0.0,0.2796443683256095,0.66,45/86,3.63%,RPS21;RPS8;RPS29;RPL19;RPL37A;RPL38;FAU;RPL8;RPS14;RPL13;RPL30;RPS20;RPL28;RPL6;RPL32;RPS13;RPL3;RPL11;RPS19;RPS11;RPL18A;RPL12;RPL23;RPS6;RPS12;RPL4;RPL14;RPS5;RPS15A;RPL39;RPL34;RPS15;RPS16;RPL7;RPS28;RPL10A;RPL22L1;RPS26;RPS7;RPL22;RPL36A;RPS10;RPL27;MRPL20;MRPL33,combination
211,gsea,Homologous recombination,0.4782662925773349,1.5410379113975439,0.030364372469635626,0.03140262060750446,0.676,13/29,40.60%,RAD54B;RAD51B;EME1;PALB2;BARD1;BRIP1;RAD54L;BRCA2;XRCC2;RPA2;RAD51;BRCA1;NBN,combination
212,gsea,Fatty acid degradation,0.41711982861270197,1.5298356435060083,0.041176470588235294,0.03399535381306295,0.699,11/34,38.69%,ACSBG2;CPT1B;ADH4;ADH7;ACSBG1;CPT2;ACADS;ACOX3;ACSL3;ACSL1;ACADL,combination
213,gsea,C-type lectin receptor signaling pathway,0.36248790673025943,1.52863224034725,0.03614457831325301,0.034094867789677144,0.701,25/83,38.26%,CLEC4E;CCL17;IL12A;CLEC4D;CLEC1B;SYK;IL10;CCL22;PTGS2;IL6;CALML4;PLCG2;IL23A;PRKCD;NLRP3;IL17D;STAT2;CARD9;PIK3CD;MAPK12;EGR2;IL1B;KSR1;MAPK11;PIK3CB,combination
214,gsea,Glucagon signaling pathway,0.378518089796093,1.5140425706413547,0.012320328542094456,0.037340348090794784,0.738,20/79,35.73%,PGAM2;LDHC;PRKAG3;PCK1;CPT1B;PLCB2;CREB3L4;PYGM;CAMK2A;CREB3L3;PHKG1;PYGL;CALML4;PPARA;PFKFB1;ADCY2;ACACB;CAMK2G;GYS2;PFKL,combination
215,gsea,Colorectal cancer,0.3471194152534594,1.4976377972293922,0.042884990253411304,0.041868444538452836,0.772,27/78,42.52%,LEF1;EREG;TCF7;DCC;PMAIP1;RAC2;EGF;BIRC5;SOS2;TGFBR2;AXIN2;SMAD3;APC2;APC;MTOR;TGFB1;RPS6KB2;TGFBR1;PIK3CD;TGFB3;RALB;PIK3CB;POLK;MLH1;MAPK9;PIK3R3;TGFB2,combination
216,gsea,Amphetamine addiction,0.36934624321466847,1.4863430450180746,0.03966597077244259,0.044902373598164284,0.789,21/56,40.40%,GRIA4;GRIA1;GRIN2B;GRIN3A;PPP1R1B;CREB3L4;CAMK2A;GRIN3B;STX1A;GRIN2D;CREB3L3;SLC18A2;GRIN2A;CALML4;ADCY5;GRIA3;CAMK2G;GRIN2C;SLC18A1;CAMK4;PRKCG,combination
217,gsea,Endocrine and other factor-regulated calcium reabsorption,0.42971310223158404,1.4613066675559796,0.038461538461538464,0.05323040059118082,0.827,9/37,32.91%,ATP1A4;PTH;ATP1A2;ESR1;PLCB2;PTH1R;ATP1A3;FXYD2;SLC8A1,combination
218,gsea,One carbon pool by folate,0.49246052391727313,1.4455010960572308,0.084,0.059365991204258985,0.858,3/15,28.32%,FTCD;ALDH1L1;MTHFD1L,combination
219,gsea,Folate biosynthesis,0.4428757888667184,1.4428518712918583,0.09563409563409564,0.060281440277724654,0.864,8/17,37.74%,PAH;TPH1;TPH2;FPGS;MOCS1;SPR;ALPL;MOCOS,combination
220,gsea,Biosynthesis of unsaturated fatty acids,0.44466015315940716,1.4377870951716405,0.09404990403071017,0.0620689999030009,0.87,8/18,38.19%,ELOVL3;BAAT;ELOVL7;ELOVL2;FADS2;ACOX3;ACOT4;ACOT7,combination
221,gsea,Spliceosome,-0.5336132346072373,-1.4344410274235713,0.045454545454545456,0.39930485593391096,0.871,59/101,21.98%,DDX5;HSPA8;HNRNPK;SRSF5;HNRNPA3;SRSF3;SNRPD2;SRSF7;TRA2B;SRSF6;SF3B2;LSM6;SNRPF;HNRNPU;HNRNPA1;SNRNP70;CWC15;SRSF9;CCDC12;SNRPD1;SYF2;BUD31;LSM4;SNW1;SF3B5;MAGOH;SNRPE;SRSF10;TXNL4A;SNRPB;SNRPD3;ZMAT2;TRA2A;ACIN1;PHF5A;U2SURP;RBM25;PRPF19;SF3B3;DHX15;NCBP2;RP9;U2AF1;SRSF1;PUF60;LSM5;RBM17;DDX46;DDX42;U2AF2;SNRPG;SF3A3;SRSF4;CDC40;PRPF6;SMNDC1;LSM3;SF3B4;PRPF18,combination
222,gsea,Kaposi sarcoma-associated herpesvirus infection,0.3219040181668951,1.4103300035143436,0.04665314401622718,0.07439966971682278,0.901,43/135,43.42%,CCR4;GNGT1;CCR3;HCK;PIK3R6;GNB3;GNG8;GNG13;SYK;FGF2;CDK6;CD86;GNG11;PIK3CG;GNGT2;PTGS2;IL6;GNG10;CALML4;PIK3R5;PLCG2;MTOR;BID;GNG3;C3;STAT2;PIK3CD;MAPK12;LYN;TNFRSF1A;MAPK11;PIK3CB;E2F1;PDGFB;GNG7;ATG3;MAPK9;MAP2K6;PIK3R3;FAS;ANGPT2;PREX1;TRAF2,combination
223,gsea,Base excision repair,0.4371801792564621,1.4040776355217266,0.08206106870229007,0.07716248179759375,0.906,15/27,49.20%,NEIL3;UNG;POLE;MUTYH;POLE3;PARP3;POLE2;SMUG1;MBD4;PCNA;OGG1;POLD1;PARP4;NTHL1;POLE4,combination
224,gsea,Adherens junction,0.3712979949052271,1.403352630001367,0.07157894736842105,0.07707133875984382,0.906,14/59,35.00%,LEF1;WAS;TCF7;SNAI1;CTNNA3;RAC2;ERBB2;TGFBR2;WASF3;SMAD3;SNAI2;PTPRB;TGFBR1;INSR,combination
225,gsea,Herpes simplex virus 1 infection,0.3121313956216639,1.3783934266804978,0.0660377358490566,0.09023940330344687,0.934,35/119,42.36%,IFNG;IL12A;NXF3;POU2F2;OAS3;TNFSF14;SYK;OAS2;POU2F3;ITGA5;EIF2B4;IL6;ZIK1;ZFP82;MAVS;CCL2;EIF2AK4;MTOR;BID;ZFP14;C3;STAT2;IRAK4;CARD9;PIK3CD;IL1B;RNASEL;TNFRSF1A;ZFP69;PIK3CB;ZFP30;CFP;EIF2AK3;PIK3R3;FAS,combination
226,gsea,Endometrial cancer,0.3559861767323751,1.3447471565799634,0.10978043912175649,0.11086508940979607,0.955,14/50,42.33%,LEF1;TCF7;CTNNA3;ERBB2;EGF;SOS2;AXIN2;APC2;APC;PIK3CD;PIK3CB;POLK;MLH1;PIK3R3,combination
227,gsea,Human cytomegalovirus infection,0.3028952553933821,1.339513469682499,0.06339468302658487,0.11393907308141972,0.959,49/163,42.42%,GNGT1;PDGFRA;CCR3;PTGER2;GNB3;IL10RA;GNG8;GNG13;PLCB2;RAC2;CREB3L4;CXCR2;PTGER1;CDK6;GNG11;CXCR4;GNGT2;CREB3L3;ADCY8;SOS2;PTGS2;IL6;GNG10;PTGER3;ADCY7;CALML4;CCL2;ADCY5;MTOR;BID;GNG3;ADCY1;ADCY2;RPS6KB2;CXCL12;PIK3CD;MAPK12;IL1B;TNFRSF1A;MAPK11;PIK3CB;E2F1;AKAP13;GNG7;PRKCG;MAP2K6;PIK3R3;FAS;PTGER4,combination
228,gsea,Viral carcinogenesis,0.3575151681289248,1.3386073465939765,0.05091649694501019,0.11405247188504183,0.959,33/135,43.82%,CCR4;TBPL2;CCR3;ATP6V0D2;CCNA1;TRAF1;CDC20;CDK1;PMAIP1;SYK;CREB3L4;CDK6;RBPJL;CCNA2;CREB3L3;SKP2;RBL1;HPN;CDK2;C3;PIK3CD;EGR2;LYN;PIK3CB;CCNE1;SCIN;PIK3R3;GTF2E1;TRAF2;GSN;CCNE2;CHEK1;MAD1L1,combination
229,gsea,DNA replication,0.41635126485143,1.3122594447473535,0.13976377952755906,0.13346740726553022,0.972,17/32,46.80%,POLA2;POLE;MCM3;MCM5;RFC4;POLE3;POLE2;PRIM2;DNA2;RPA2;MCM6;MCM4;PCNA;MCM7;POLD1;RFC3;MCM2,combination
230,gsea,Parkinson disease,-0.5055208250070328,-1.2895336296260969,0.17716535433070865,0.717811807374572,0.975,60/94,13.73%,UBB;COX8A;COX6C;COX4I1;COX7A2L;COX7C;GNAI2;NDUFA2;UQCRB;UQCRQ;PRKACB;COX6B1;NDUFA1;NDUFB9;UQCR11;UQCR10;NDUFC2;NDUFS5;SLC25A4;NDUFV3;COX7B;NDUFB7;COX6A1;NDUFA4;NDUFB2;SLC25A5;NDUFC1;NDUFB3;PARK7;NDUFS2;VDAC2;NDUFS6;NDUFA12;SDHA;COX6A2;NDUFB4;NDUFB5;NDUFA8;NDUFS3;NDUFA5;UQCRFS1;NDUFB6;COX5A;COX7A2;NDUFS4;NDUFA6;SDHC;VDAC1;NDUFAB1;UQCRC2;NDUFV2;NDUFV1;NDUFS8;NDUFA13;CYC1;GNAI3;NDUFA10;NDUFS7;UBE2J1;NDUFA7,combination
231,gsea,Longevity regulating pathway,0.3121853305469635,1.2888921779329818,0.12368972746331237,0.15267176403386867,0.984,25/82,42.33%,EIF4E1B;PRKAG3;ADIPOQ;IGF1;CREB3L4;CREB3L3;CRYAB;ADCY8;CAMKK2;ADCY7;CAT;CLPB;ADCY5;MTOR;ADCY1;ADCY2;EHMT1;RPS6KB2;INSR;PIK3CD;PIK3CB;CAMK4;PPARG;ULK1;PIK3R3,combination
232,gsea,Other types of O-glycan biosynthesis,0.39768931862467005,1.2490830412337253,0.210727969348659,0.18966352051586816,0.992,8/20,42.96%,LFNG;ST6GAL2;ST3GAL3;GXYLT2;COLGALT2;MFNG;PLOD3;EOGT,combination
233,gsea,Endocytosis,0.30567764783898205,1.233324886161609,0.12108559498956159,0.2046879181016996,0.994,41/198,38.08%,CXCR1;PDGFRA;CAPZA3;IL2RG;PSD2;IL2RA;ARAP3;WAS;CAV3;HGS;FOLR2;CYTH4;FGFR3;CXCR2;DAB2;IL2RB;EHD2;PIP5KL1;CXCR4;FGFR4;PLD2;RAB22A;TGFBR2;WIPF3;WIPF1;GIT1;SMAD3;EPN3;FGFR2;CAV1;CBLC;AGAP2;PARD6B;MVB12B;TGFBR1;CAV2;GRK6;ASAP1;ARAP2;EHD3;ACAP3,combination
234,gsea,Cellular senescence,0.28058257397906583,1.2309211143280372,0.1566265060240964,0.206377567902285,0.994,49/126,48.65%,CCNB3;CCNB1;CCNA1;TRPV4;FOXM1;CDK1;HIPK4;IL1A;CDK6;CCNB2;CCNA2;SLC25A31;IL6;TGFBR2;CALML4;RBL1;SMAD3;MTOR;TGFB1;CDK2;ETS1;SERPINE1;CHEK2;ZFP36L1;TGFBR1;MYBL2;PIK3CD;MAPK12;IGFBP3;TGFB3;MAPK11;PIK3CB;E2F1;NBN;CCNE1;MAP2K6;PIK3R3;TGFB2;CCNE2;CHEK1;RASSF5;CACNA1D;MAP2K1;RRAS2;LIN9;E2F3;SIRT1;PPP3CC;RAD9B,combination
235,gsea,ErbB signaling pathway,0.2933499717467537,1.2155542903952348,0.1851106639839034,0.221904886597797,0.996,27/76,45.86%,EREG;NRG3;ERBB2;EGF;CAMK2A;SHC3;ERBB4;SOS2;BTC;NRG2;PLCG2;MTOR;RPS6KB2;NRG4;CAMK2G;PIK3CD;ERBB3;PIK3CB;PRKCG;NRG1;MAPK9;SHC4;PIK3R3;PAK1;MAP2K1;NCK2;STAT5A,combination
236,gsea,Alzheimer disease,-0.4189014582832985,-1.206948911270186,0.2372549019607843,0.8783900866411446,0.991,76/125,24.94%,CALM1;COX8A;COX6C;COX4I1;COX7A2L;ATP2A2;COX7C;NDUFA2;UQCRB;UQCRQ;COX6B1;NDUFA1;NDUFB9;UQCR11;UQCR10;NDUFC2;NDUFS5;NDUFV3;COX7B;NDUFB7;COX6A1;CALM2;NDUFA4;RTN4;NDUFB2;ATP2A3;NDUFC1;NDUFB3;NDUFS2;BACE2;NDUFS6;NDUFA12;SDHA;COX6A2;NDUFB4;GSK3B;NDUFB5;NDUFA8;NDUFS3;NDUFA5;UQCRFS1;NDUFB6;MAPK3;COX5A;COX7A2;NDUFS4;NDUFA6;SDHC;RTN3;NDUFAB1;UQCRC2;ATF6;NDUFV2;MAPK1;NDUFV1;NDUFS8;PPP3CB;NDUFA13;CYC1;CALM3;APP;NDUFA10;LPL;NDUFS7;APH1A;NDUFA7;HSD17B10;ERN1;NCSTN;SDHB;CAPN2;ITPR1;NAE1;ADAM10;APBB1;IDE,combination
237,gsea,Legionellosis,0.3341798098234637,1.1976142552202975,0.21526418786692758,0.24141311377352656,0.997,10/37,37.83%,IL12A;ITGAM;TLR5;TLR4;CD14;IL6;NLRC4;C3;IL1B;CASP7,combination
238,gsea,RNA degradation,0.34898186331181735,1.1904984952692743,0.19801980198019803,0.24877084786256914,0.997,15/58,44.98%,BTG4;EXOSC6;PNLDC1;PABPC4L;ENO4;PFKL;PABPC5;PNPT1;DIS3L;LSM1;ENO2;XRN1;ENO3;PABPC1L;XRN2,combination
239,gsea,Insulin signaling pathway,0.2959805755011442,1.1843682400430322,0.17165668662674652,0.25469060864496346,0.997,27/118,36.18%,EIF4E1B;PRKAG3;PPP1R3A;PCK1;SH2B2;HK2;HKDC1;PYGM;HK1;FBP2;HK3;SHC3;SOS2;SOCS1;PHKG1;PPP1R3D;PYGL;CALML4;PPP1R3E;MTOR;PPP1R3C;RPS6KB2;ACACB;TRIP10;INSR;GYS2;PIK3CD,combination
240,gsea,Apoptosis,0.28058568009302987,1.1816319332112861,0.20404040404040405,0.2568251296339293,0.997,40/110,47.76%,PRF1;SPTA1;BIRC7;TRAF1;CTSS;PMAIP1;NGFR;NGF;BIRC5;HRK;CTSW;LMNB1;CTSK;TUBA8;DFFA;BID;PARP3;CTSZ;DAB2IP;CTSC;PIK3CD;NTRK1;CASP7;TNFRSF1A;PIK3CB;BOK;TUBA4A;LMNB2;MAPK9;EIF2AK3;PIK3R3;FAS;HTRA2;TRAF2;TNFSF10;MAP2K1;PARP4;CASP6;BBC3;BAK1,combination
241,gsea,Fatty acid elongation,0.36035492826306403,1.172329277402727,0.2529182879377432,0.26697690256657697,0.997,8/20,46.45%,ELOVL3;THEM5;ELOVL7;ELOVL2;ACOT4;ACOT7;ELOVL4;THEM4,combination
242,gsea,Lysine degradation,0.3044345227994789,1.1663215248493908,0.2759295499021526,0.2733088172731868,0.998,21/44,52.32%,AADAT;BBOX1;PIPOX;PRDM6;PLOD2;SUV39H2;AASS;EHMT1;COLGALT2;CAMKMT;SETDB2;EZH2;PLOD3;ALDH1B1;SETD2;KMT2B;DHTKD1;SUV39H1;KMT2D;ALDH2;EHHADH,combination
243,gsea,Protein processing in endoplasmic reticulum,-0.47198583374992503,-1.1538076993180704,0.3463035019455253,0.9330294176909129,0.996,96/137,22.94%,HSP90AB1;HSP90B1;HSPA5;SSR4;HSPA8;CALR;SEC61G;SEC61B;DAD1;HSP90AA1;PDIA3;HERPUD1;ATF4;XBP1;PDIA6;DNAJC3;DDOST;P4HB;SEC62;RRBP1;LMAN1;RBX1;VCP;SSR2;SAR1A;SSR1;DDIT3;RPN1;SEC61A1;SEC31A;DNAJA1;ERP29;TRAM1;STUB1;BAG1;STT3A;LMAN2;OS9;PPP1R15A;SEC63;DERL2;HSPH1;UBQLN2;DERL1;SSR3;SAR1B;ERLEC1;SEC23B;PDIA4;DNAJB11;UGGT1;DNAJC1;ATF6;DNAJC5;DNAJA2;PRKCSH;SEL1L;EDEM2;BCAP31;RAD23B;AMFR;UBE4B;SEC24D;PREB;UBXN6;SEC13;GANAB;UBQLN1;DNAJB1;MAN1A2;HSPA4L;DNAJB2;UBE2J1;SVIP;DNAJC10;MBTPS1;WFS1;ERN1;SEC24C;SIL1;CUL1;TXNDC5;FBXO2;SEC24A;MAPK10;PLAA;STT3B;UBE2G1;CAPN2;DNAJB12;NPLOC4;EIF2S1;YOD1;SEC23A;SEC24B;MAP2K7,combination
244,gsea,Notch signaling pathway,0.30880962159325953,1.1534282269908895,0.2925430210325048,0.2883395093878521,0.999,17/40,48.95%,LFNG;RBPJL;PTCRA;DLL3;NOTCH3;DTX1;JAG1;JAG2;DTX4;MFNG;CIR1;NOTCH2;CTBP2;DVL1;DLL4;NUMB;MAML2,combination
245,gsea,Non-alcoholic fatty liver disease (NAFLD),-0.39042354180207856,-1.1290424972494333,0.35589941972920697,0.8872801588900722,0.999,76/120,22.61%,COX8A;COX6C;COX4I1;COX7A2L;COX7C;ATF4;XBP1;NDUFA2;UQCRB;UQCRQ;COX6B1;NDUFA1;NDUFB9;UQCR11;UQCR10;NDUFC2;NDUFS5;CDC42;JUN;NDUFV3;COX7B;NDUFB7;COX6A1;NDUFA4;NDUFB2;DDIT3;NDUFC1;NDUFB3;NDUFS2;NDUFS6;NDUFA12;SDHA;COX6A2;NDUFB4;GSK3B;NDUFB5;NDUFA8;IRS2;RAC1;NDUFS3;NDUFA5;UQCRFS1;NDUFB6;COX5A;COX7A2;NDUFS4;NDUFA6;SDHC;NDUFAB1;UQCRC2;NDUFV2;NDUFV1;NDUFS8;NDUFA13;CYC1;MLXIPL;NDUFA10;PIK3R1;NDUFS7;SOCS3;PRKAB2;RELA;NDUFA7;ERN1;SREBF1;GSK3A;SDHB;PIK3CA;MAPK10;AKT2;AKT1;PRKAG2;NFKB1;EIF2S1;PRKAA1;ITCH,combination
246,gsea,Phosphatidylinositol signaling system,0.27048135122476347,1.1059753010093931,0.33539094650205764,0.3500657633512011,1.0,24/86,43.39%,PLCZ1;PLCD3;PLCD1;INPP4B;PLCB2;IMPA2;DGKI;PLCE1;INPP5J;CALML4;PLCG2;PIK3C2B;PLCD4;IP6K3;PIK3CD;PIK3CB;DGKA;MTMR4;PRKCG;PIK3C2G;DGKQ;PIK3R3;SYNJ2;ITPKA,combination
247,gsea,Lysosome,0.29844080212820073,1.102832663665255,0.2860125260960334,0.3533299640749738,1.0,26/106,47.28%,CTSE;CTSG;ATP6V0D2;NAPSA;CTSS;ACP5;SLC11A1;LAPTM5;ATP6V0A4;CTSW;CTSK;CTSZ;AP3B1;CTSC;AP1G2;AP4M1;AP1B1;ARSG;GLB1;AP1M1;FUCA1;AP4E1;TCIRG1;LIPA;MANBA;AP1S3,combination
248,gsea,Proteasome,0.48108927555948944,1.0934207438061354,0.4027504911591356,0.36533946317908633,1.0,2/34,3.97%,PSMA8;IFNG,combination
249,gsea,Aminoacyl-tRNA biosynthesis,0.3490824821344395,1.0899908683825665,0.3611111111111111,0.36849882883125773,1.0,12/21,52.24%,PARS2;QRSL1;WARS2;MTFMT;HARS2;DARS2;FARSA;AARS2;NARS2;FARS2;PSTK;YARS2,combination
250,gsea,Oxidative phosphorylation,-0.4774235957410706,-1.084970214002325,0.45634920634920634,0.9244849385452347,0.999,65/86,17.44%,COX8A;COX6C;COX4I1;COX7A2L;COX7C;ATP6V0B;NDUFA2;ATP6V1F;UQCRB;ATP6V1G1;UQCRQ;COX6B1;NDUFA1;NDUFB9;UQCR11;UQCR10;NDUFC2;NDUFS5;NDUFV3;COX7B;NDUFB7;COX6A1;NDUFA4;ATP6V1E1;NDUFB2;NDUFC1;NDUFB3;NDUFS2;COX17;NDUFS6;NDUFA12;SDHA;COX6A2;NDUFB4;ATP6AP1;NDUFB5;NDUFA8;ATP6V1D;ATP6V1B2;NDUFS3;NDUFA5;UQCRFS1;NDUFB6;COX5A;COX7A2;NDUFS4;NDUFA6;ATP6V0D1;SDHC;ATP6V1A;NDUFAB1;UQCRC2;NDUFV2;PPA1;NDUFV1;NDUFS8;NDUFA13;CYC1;ATP6V1C1;NDUFA10;NDUFS7;NDUFA7;ATP6V1H;SDHB;ATP6V0A1,combination
251,gsea,Mismatch repair,0.37880188396442943,1.0847439771304719,0.3630705394190871,0.3748685953452647,1.0,13/20,55.16%,EXO1;RFC4;RPA2;PMS2;MLH1;PCNA;POLD1;RFC3;MSH2;RFC5;MSH6;RFC1;LIG1,combination
252,gsea,N-Glycan biosynthesis,-0.3416562035440909,-1.0839725517617225,0.3176470588235294,0.8252736919873732,0.999,21/42,33.93%,DAD1;DDOST;DPM3;RPN1;STT3A;DPM1;DPM2;GANAB;ALG2;MAN1A2;MGAT2;ALG5;STT3B;B4GALT3;MAN1B1;ALG12;MGAT1;MAN2A1;FUT8;ALG11;ST6GAL1,combination
253,gsea,Non-small cell lung cancer,0.2821136015024901,1.075534618352153,0.34663865546218486,0.38663563102429777,1.0,21/58,49.02%,RXRG;RARB;ERBB2;EGF;CDK6;SOS2;ALK;PLCG2;PIK3CD;PIK3CB;E2F1;POLK;PRKCG;PIK3R3;RASSF5;MAP2K1;STAT5A;DDB2;BAK1;E2F3;EGFR,combination
254,gsea,Type II diabetes mellitus,0.28895946739455336,1.0718189365615562,0.34368530020703936,0.3909165669977129,1.0,16/39,44.08%,ADIPOQ;HK2;HKDC1;HK1;HK3;SOCS1;CACNA1G;MTOR;PRKCD;INSR;PIK3CD;PIK3CB;CACNA1E;MAPK9;PIK3R3;CACNA1D,combination
255,gsea,Hepatitis B,0.2481238331226615,1.069553389632783,0.3797216699801193,0.3928059887199099,1.0,43/130,47.20%,SLC10A1;MMP9;CCNA1;TLR4;CREB3L4;CCNA2;CREB3L3;BIRC5;SOS2;IL6;STAT4;HSPG2;TGFBR2;MAVS;SMAD3;TIRAP;TGFB1;BID;CDK2;TGFBR1;STAT2;IRAK4;PIK3CD;MAPK12;EGR2;TGFB3;MAPK11;PIK3CB;E2F1;PRKCG;CCNE1;PCNA;MAPK9;MAP2K6;PIK3R3;FAS;TGFB2;CCNE2;MAP2K1;STAT5A;TLR3;DDB2;MYD88,combination
256,gsea,Glioma,0.2615533394272222,1.0589199155130211,0.36088709677419356,0.40654279300915164,1.0,27/63,49.02%,PDGFRA;PDGFRB;IGF1;EGF;CAMK2A;CDK6;SHC3;SOS2;CALML4;PLCG2;MTOR;CAMK2G;PIK3CD;PIK3CB;E2F1;POLK;CAMK4;PDGFB;PRKCG;SHC4;PIK3R3;CAMK1G;MAP2K1;DDB2;BAK1;E2F3;EGFR,combination
257,gsea,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.3367130750605327,-1.0195419180890473,0.44793713163064836,0.9310699173886763,1.0,21/21,66.39%,PIGP;DPM2;PIGK;PIGT;PIGX;PIGF;PIGU;GPAA1;PIGG;PIGC;PIGO;PIGN;PIGA;PIGQ;PIGL;PIGM;PIGV;PIGB;GPLD1;PGAP1;PIGH,combination
258,gsea,Renal cell carcinoma,-0.3006109909162762,-1.013080801113548,0.45109780439121755,0.8646850328796732,1.0,32/57,32.74%,RBX1;CDC42;JUN;RAP1B;KRAS;ARAF;VEGFA;RAC1;BRAF;MAPK3;MAP2K2;MAPK1;PTPN11;GRB2;PAK3;PIK3R1;EP300;EGLN1;PAK2;CREBBP;PIK3CA;AKT2;AKT1;NRAS;ARNT;CDKN1A;CUL2;HIF1A;SOS1;CRKL;BAD;RAPGEF1,combination
259,gsea,Thermogenesis,-0.2820242870302928,-1.0099793126828878,0.47326732673267324,0.8008512996171672,1.0,176/176,95.78%,ACTB;COX8A;COX6C;RPS6;COX4I1;COX7A2L;COX7C;NDUFA2;UQCRB;UQCRQ;PRKACB;COX6B1;NDUFA1;NDUFB9;UQCR11;UQCR10;NDUFC2;NDUFS5;GNAS;NDUFV3;COX7B;NDUFB7;COX6A1;NDUFA4;NDUFB2;NDUFC1;NDUFB3;RHEB;NDUFS2;COX14;COX17;KRAS;NDUFS6;NDUFA12;SDHA;COX6A2;NDUFB4;NDUFB5;NDUFA8;NDUFS3;NDUFA5;UQCRFS1;NDUFB6;COX5A;COX7A2;NDUFS4;NDUFA6;CREB3L2;SDHC;NDUFAB1;UQCRC2;NDUFV2;GCG;NDUFV1;SMARCA4;NDUFS8;SMARCA2;ARID1A;NDUFA13;CYC1;ATF2;GRB2;SMARCC2;MAPK14;NDUFA10;NDUFAF3;NDUFS7;PRKAB2;NDUFA7;SMARCE1;ARID1B;SDHB;NDUFAF4;SMARCC1;TSC1;RPS6KA3;COA5;PRKAG2;NRAS;CREB3L1;PRKAA1;ACTL6B;ACSL4;TSC2;COX18;SMARCD2;SOS1;NDUFAF7;CREB3;COX16;FRS2;NDUFAF2;NDUFAF6;UQCRC1;COA7;COA6;PRKAB1;CPT1A;MAP3K5;AKT1S1;MAP2K3;COX11;SLC25A29;KDM3B;SIRT6;COX10;KDM3A;PPARGC1A;CREB1;RPS6KB1;NDUFAF1;PRKAG1;CREB5;COX19;MAPK13;ADCY9;CPT1C;ACSL6;COX20;RPTOR;PRKAA2;KLB;COX15;ADCY3;PNPLA2;RPS6KA2;ADCY6;LIPE;ACSL5;FGFR1;ACTL6A;MLST8;KDM1A;RPS6KA6;COX7A1;SMARCD1;PPARG;MAPK11;ACSL1;ACSL3;MAPK12;PRDM16;COX7B2;RPS6KB2;ADCY2;ADCY1;COX6B2;NPR1;MTOR;ADCY5;SLC25A20;DPF3;NDUFAF5;MGLL;ADCY7;CPT2;DPF1;UCP1;PRKG1;NPPB;SOS2;ADCY8;CREB3L3;NDUFA4L2;NPPA;CNR1;CREB3L4;COX4I2;ADCY10;SMARCD3;FGF21;CPT1B;PLIN1;PRKG2;PRKAG3;ADRB3,combination
260,gsea,Circadian rhythm,0.33257993852316403,0.948986468674305,0.5557894736842105,0.5756151467095303,1.0,8/28,57.18%,PRKAG3;RORB;NPAS2;RORC;CLOCK;PRKAA2;PRKAG1;CREB1,combination
261,gsea,Citrate cycle (TCA cycle),-0.42386510092387475,-0.9458005974126492,0.5663366336633663,0.8958058866380446,1.0,20/24,23.80%,ACLY;MDH1;SDHA;MDH2;ACO2;SDHC;IDH2;DLD;SUCLG1;OGDH;IDH3B;SUCLA2;PDHB;PDHA1;SDHB;SUCLG2;IDH3A;OGDHL;IDH1;DLST,combination
262,gsea,Terpenoid backbone biosynthesis,0.35546887613940203,0.9301833602664725,0.5661914460285132,0.6022618622195751,1.0,4/20,48.00%,HMGCS2;PDSS2;FNTB;PDSS1,combination
263,gsea,SNARE interactions in vesicular transport,0.278770089688943,0.9165573703581665,0.572,0.6210725887397404,1.0,9/25,43.46%,STX1A;STX2;STX19;STX11;STX1B;STX16;VAMP5;VAMP1;BNIP1,combination
264,gsea,Huntington disease,-0.29902818268121806,-0.9059999559710494,0.6313725490196078,0.9217351256440517,1.0,139/139,97.10%,COX8A;COX6C;COX4I1;COX7A2L;COX7C;NDUFA2;UQCRB;UQCRQ;COX6B1;NDUFA1;CLTA;NDUFB9;CLTC;UQCR11;UQCR10;NDUFC2;NDUFS5;SLC25A4;NDUFV3;COX7B;NDUFB7;COX6A1;NDUFA4;NDUFB2;SLC25A5;NDUFC1;NDUFB3;NDUFS2;CLTB;VDAC2;NDUFS6;NDUFA12;SDHA;COX6A2;NDUFB4;NDUFB5;NDUFA8;NDUFS3;NDUFA5;UQCRFS1;NDUFB6;COX5A;COX7A2;NDUFS4;NDUFA6;CREB3L2;SOD1;SDHC;POLR2F;VDAC1;NDUFAB1;UQCRC2;POLR2C;NDUFV2;NDUFV1;AP2S1;NDUFS8;NDUFA13;CYC1;IFT57;POLR2E;NDUFA10;POLR2I;EP300;POLR2G;NDUFS7;NDUFA7;AP2A1;CREBBP;HTT;VDAC3;SP1;SDHB;DCTN4;CREB3L1;TFAM;AP2B1;ITPR1;HDAC1;RCOR1;SIN3A;CREB3;DLG4;PLCB1;TBPL1;UQCRC1;NRF1;GRIN1;DCTN2;PLCB4;TBP;POLR2D;BAX;TAF4B;DCTN1;CASP8;CASP9;CASP3;PPARGC1A;HDAC2;CREB1;CREB5;POLR2B;PLCB3;BDNF;APAF1;POLR2L;DNAL1;BBC3;DNAH11;COX7A1;HIP1;PPIF;DNAH2;PPARG;REST;COX7B2;DNAH9;COX6B2;DNAH8;GRM5;TGM2;UCP1;DNAH6;SLC25A31;CREB3L3;NDUFA4L2;CREB3L4;COX4I2;DNALI1;PLCB2;DNAH5;GRIN2B;DNAH17;DNAH14;DNAH12;DNAH3;DNAH1;TBPL2,combination
265,gsea,"Valine, leucine and isoleucine degradation",0.2512900987171321,0.8787484312836105,0.6640316205533597,0.6774606010758482,1.0,10/42,45.12%,HMGCS2;BCAT1;IL4I1;BCAT2;AGXT2;ACADS;IVD;AOX1;DBT;ALDH1B1,combination
266,gsea,Ferroptosis,0.25962737660734975,0.8742758722677615,0.6310679611650486,0.6815042990173114,1.0,15/32,54.57%,ALOX15;CP;STEAP3;SLC39A8;ACSL3;ACSL1;SAT2;MAP1LC3A;SLC7A11;ACSL5;NCOA4;SLC39A14;SLC40A1;ACSL6;HMOX1,combination
267,gsea,Long-term potentiation,0.24218081932125335,0.8708458045104451,0.6824457593688363,0.6832965582250402,1.0,18/55,45.21%,GRIA1;GRIN2B;PLCB2;CAMK2A;GRM1;GRIN2D;ADCY8;GRIN2A;CALML4;GRM5;ADCY1;RAPGEF3;CAMK2G;GRIN2C;CAMK4;PRKCG;RPS6KA6;MAP2K1,combination
268,gsea,Autophagy,-0.24844560347835623,-0.8590267924680864,0.7799607072691552,0.956890993350796,1.0,105/105,87.48%,GABARAP;LAMP1;PRKACB;GABARAPL2;RHEB;CTSD;LAMP2;KRAS;VAMP8;SH3GLB1;IRS2;MAPK3;MAP2K2;RRAGA;RB1CC1;MAPK1;BNIP3;DEPTOR;VMP1;PDPK1;GABARAPL1;BECN1;PIK3R1;ATG13;RRAGC;CFLAR;IGF1R;MTMR3;ERN1;STK11;ATG5;PIK3CA;RAB33B;MAPK10;WIPI1;AKT2;AKT1;TSC1;NRAS;ITPR1;EIF2S1;PRKAA1;BCL2L1;NRBF2;ATG16L2;UVRAG;HIF1A;TSC2;MRAS;DAPK3;DDIT4;ATG4D;RRAGD;PIK3R4;ATG12;ATG10;STX17;PIK3C3;BAD;TRAF6;AKT1S1;ZFYVE1;ULK2;RAF1;ATG14;DAPK1;MAP3K7;RRAS;MAPK8;ATG9A;ATG7;SNAP29;RRAGB;RPS6KB1;BCL2;ATG2B;PPP2CB;RPTOR;PRKAA2;WIPI2;ATG4B;MTMR14;IRS1;ATG2A;ATG4C;MLST8;AMBRA1;RRAS2;MAP2K1;PIK3R3;EIF2AK3;MAPK9;ULK1;ATG3;MTMR4;PIK3CB;PIK3CD;RPS6KB2;PRKCD;MTOR;EIF2AK4;CAMKK2;DAPK2;ATG9B;PRKCQ,combination
269,gsea,Neurotrophin signaling pathway,-0.21542952543871696,-0.836960342189041,0.7963709677419355,0.9380100241789241,1.0,101/101,89.28%,CALM1;MAGED1;ATF4;CDC42;JUN;RAP1B;CALM2;RHOA;KRAS;GSK3B;ARHGDIA;RAC1;BRAF;MAPK3;MAP2K2;NTRK2;KIDINS220;IRAK1;MAPK1;PTPN11;CAMK2B;CALM3;NFKBIA;GRB2;MAPK14;PDPK1;SHC1;PIK3R1;RELA;SORT1;PIK3CA;MAPK10;AKT2;AKT1;MAPKAPK2;RPS6KA3;NRAS;NFKB1;MAP2K7;SOS1;IKBKB;ABL1;PSEN2;FRS2;CRKL;BAD;TRAF6;RAPGEF1;MAP3K1;MAP3K5;SH2B1;RAP1A;BAX;RAF1;MAP2K5;NFKBIE;MAPK8;MAP3K3;SH2B3;GAB1;BCL2;IRAK2;MAPK13;PSEN1;PLCG1;RIPK2;CRK;BDNF;PRDM4;IRS1;MAPK7;RPS6KA2;ARHGDIG;MAP2K1;RPS6KA6;PIK3R3;SHC4;MAPK9;RPS6KA5;CAMK4;PIK3CB;MAPK11;MATK;NTRK1;MAPK12;PIK3CD;IRAK4;CAMK2G;PRKCD;NTRK3;IRAK3;PLCG2;CALML4;SOS2;SHC3;ARHGDIB;NGF;CAMK2A;NGFR;NTF3;SH2B2,combination
270,gsea,Mitophagy,-0.2712388015312667,-0.815576767809596,0.7977099236641222,0.9188791172322243,1.0,52/52,99.08%,UBB;GABARAP;ATF4;GABARAPL2;TOMM7;JUN;TAX1BP1;KRAS;NBR1;BNIP3;USP15;CITED2;GABARAPL1;BECN1;TBC1D15;RELA;FIS1;SP1;ATG5;TBC1D17;MAPK10;NRAS;MFN2;BCL2L1;FUNDC1;HIF1A;MRAS;RHOT1;USP8;TBK1;PINK1;MFN1;BNIP3L;USP30;OPTN;PGAM5;CSNK2A2;RRAS;MAPK8;ATG9A;RHOT2;BCL2L13;AMBRA1;RRAS2;EIF2AK3;MAPK9;ULK1;E2F1;MITF;TFEB;ATG9B;CALCOCO2,combination
271,gsea,Bacterial invasion of epithelial cells,0.2238451533781335,0.7999906528687011,0.8187372708757638,0.7801072066706373,1.0,24/58,55.07%,WAS;CTNNA3;CAV3;HCLS1;FN1;SHC3;ITGA5;ARHGAP10;CAV1;CAV2;PIK3CD;PIK3CB;WASF1;SHC4;PIK3R3;DNM1;ELMO1;MET;DOCK1;CRK;CTNNA2;PXN;ARPC5L;ELMO2,combination
272,gsea,RNA polymerase,-0.27018234092456683,-0.7932187909723504,0.7589098532494759,0.9028309490227685,1.0,20/20,73.03%,POLR2F;POLR1D;POLR2C;POLR2E;POLR3K;POLR2I;POLR2G;POLR3D;POLR1C;POLR3H;POLR2D;POLR3C;POLR2B;POLR2L;POLR3A;POLR1B;POLR1E;POLR3F;POLR1A;POLR3B,combination
273,gsea,Nucleotide excision repair,-0.2265909090909091,-0.7925563926850309,0.7456310679611651,0.8563634049863728,1.0,37/37,77.41%,RBX1;DDB1;RAD23B;GTF2H5;POLD4;CUL4A;RAD23A;CUL4B;CCNH;POLD2;RPA3;ERCC5;RFC2;MNAT1;GTF2H3;RPA1;ERCC3;ERCC2;XPA;LIG1;RFC1;RFC5;ERCC4;XPC;POLE4;ERCC6;ERCC8;DDB2;RFC3;POLD1;ERCC1;PCNA;RPA2;POLE2;POLE3;RFC4;POLE,combination
274,gsea,Pancreatic cancer,0.18825095137826592,0.7473282950221283,0.8492871690427699,0.8433285096535637,1.0,28/69,49.02%,RAC2;ERBB2;EGF;CDK6;TGFBR2;SMAD3;MTOR;TGFB1;BRCA2;RPS6KB2;TGFBR1;PIK3CD;RAD51;TGFB3;RALB;PIK3CB;E2F1;ARHGEF6;POLK;MAPK9;PIK3R3;TGFB2;PLD1;MAP2K1;DDB2;BAK1;E2F3;EGFR,combination
275,gsea,Chronic myeloid leukemia,-0.2016098412939479,-0.7399490144931176,0.883495145631068,0.880226173685271,1.0,68/68,79.95%,GADD45G;KRAS;GADD45B;ARAF;BRAF;MAPK3;MAP2K2;MAPK1;PTPN11;CTBP1;NFKBIA;GRB2;SHC1;CDKN1B;PIK3R1;BCR;RELA;SMAD4;MDM2;PIK3CA;AKT2;AKT1;NRAS;GADD45A;NFKB1;HDAC1;BCL2L1;CBL;CDKN1A;SOS1;STAT5B;CDK4;IKBKB;ABL1;CHUK;RB1;CRKL;IKBKG;BAD;BAX;RAF1;CCND1;HDAC2;GAB2;CRK;E2F3;BAK1;DDB2;STAT5A;MAP2K1;CTBP2;TGFB2;PIK3R3;SHC4;POLK;E2F1;PIK3CB;MECOM;TGFB3;PIK3CD;TGFBR1;TGFB1;SMAD3;TGFBR2;RUNX1;SOS2;SHC3;CDK6,combination
276,gsea,mRNA surveillance pathway,-0.22885580625853277,-0.7184038519200959,0.9252525252525252,0.8613741688494861,1.0,71/71,92.29%,PPP1CB;PAPOLA;MSI2;PPP1CA;SRRM1;PPP2R5C;UPF3B;PNN;SSU72;MAGOH;GSPT1;PPP2R5A;ETF1;CSTF3;SMG1;ACIN1;PPP2R2D;PPP1CC;DAZAP1;NCBP2;NXF1;CASC3;RNMT;PCF11;HBS1L;PPP2R2A;PABPC4;CPSF7;CPSF6;PPP2R1A;UPF1;SMG7;PPP2R5B;CPSF3;UPF2;PPP2R3C;UPF3A;PPP2R3A;NCBP1;SMG6;SMG5;SYMPK;PPP2R5E;CSTF2;RNPS1;PPP2R1B;NUDT21;GSPT2;CLP1;NXT2;WDR33;CSTF2T;PPP2R2C;PPP2CB;WDR82;PAPOLG;CPSF2;MAGOHB;NXT1;MSI1;PABPC1L;PPP2R5D;CSTF1;PPP2R2B;CPSF4;PABPN1;PABPC5;RNGTT;PABPC4L;PABPN1L;NXF3,combination
277,gsea,RNA transport,0.19123628493874906,0.6392787341339562,0.9736842105263158,0.9383843604022838,1.0,31/118,47.59%,POM121L2;EIF4E1B;NXF3;NUP210L;THOC3;GEMIN2;EIF2B4;PABPC4L;NUP133;RPP40;THOC5;POP4;DDX20;TGS1;RPP25;GEMIN4;PABPC5;NDC1;NUP205;PRMT5;POP1;NUP107;GEMIN5;NUP85;PABPC1L;TACC3;NUP155;NXT1;EIF3B;NUP160;MAGOHB,combination
278,gsea,Ubiquitin mediated proteolysis,0.184820583012861,0.6160918119723819,0.9978858350951374,0.9488975380632928,1.0,35/118,57.05%,BIRC7;AIRE;UBE2U;CDC20;SOCS1;SKP2;UBA7;UBE2C;CBLC;DET1;UBOX5;FANCL;UBE2F;MID1;BRCA1;NHLRC1;UBE3B;UBE2L6;UBE2E1;FBXO4;DDB2;FBXW8;ERCC8;SMURF1;PML;UBA3;RHOBTB2;UBE2J2;SYVN1;PIAS4;UBR5;TRIM32;PIAS2;UBA2;WWP1,combination
279,gsea,Ribosome biogenesis in eukaryotes,0.15698359537662634,0.5747846220748672,0.9285714285714286,0.9654839899032871,1.0,24/62,53.12%,NXF3;FBLL1;RPP40;POP4;PWP2;RPP25;WDR3;RIOK2;XRN1;POP1;RIOK1;XRN2;BMS1;NVL;NXT1;NAT10;TCOF1;HEATR1;UTP6;RPP30;WDR36;REXO1;RBM28;WDR75,combination
